<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg width="2400" height="2400" xmlns="http://www.w3.org/2000/svg" style="background-color:black">
<circle cx="1200" cy="1200" r="1052" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1028" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1026" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="175" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="173" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="161" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<text font-size="4.0em" x="50" y="60" fill="white">SARS-CoV-2 mutations 2020 timemap</text>
<text font-size="2.8em" x="50" y="105" fill="white">Genbank MN908947 vs 3,447 GISAID genomes</text>
<line x1="1200" y1="83.1314031180401" x2="1200" y2="133.13140311804" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1176" y="73.1314031180401" fill="white">Winter</text>
<line x1="2267" y1="1200" x2="2317" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="2267" y="1245" fill="white">Spring</text>
<line x1="1200" y1="2267" x2="1200" y2="2317" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1045" y="2352" fill="white">Summer</text>
<line x1="133" y1="1200" x2="73" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="59" y="1185" fill="white">Fall</text>
<g>	<title>orf1ab gene (21500-21555)</title>
	<line x1="1208" y1="1039" x2="1208" y2="1027" style="stroke:grey;stroke-width:8" />
</g><g>	<title>S gene (21563-25384)</title>
	<line x1="1208" y1="1025" x2="1208" y2="174" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF3a gene (25393-25500)</title>
	<line x1="1208" y1="172" x2="1208" y2="148" style="stroke:grey;stroke-width:8" />
</g><line x1="1200" y1="148.13140311804" x2="1200" y2="1039" style="stroke:white;stroke-width:3" />
<line x1="1204" y1="148.13140311804" x2="1210" y2="148.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="148.13140311804" x2="1215" y2="123.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1204" y1="1039" x2="1210" y2="1039" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="1039" x2="1215" y2="1064" style="stroke:white;stroke-width:2" />
<text font-size="2.0em" x="1215" y="123.13140311804" fill="white">25.5 kb</text>
<text font-size="2.0em" x="1215" y="1084" fill="white">21.5 kb</text>
<text font-size="2.5em" x="110" y="175" fill="white">Top countries</text>
<circle cx="60" cy="205" r="8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="215" fill="white">South Africa</text>
<circle cx="60" cy="235" r="8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="245" fill="white">SaudiArabia</text>
<circle cx="60" cy="265" r="8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="275" fill="white">Gambia</text>
<circle cx="60" cy="295" r="8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="305" fill="white">DRC</text>
<circle cx="60" cy="325" r="8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="335" fill="white">Uganda</text>
<circle cx="60" cy="355" r="8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="365" fill="white">Nigeria</text>
<circle cx="60" cy="385" r="8" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="395" fill="white">Egypt</text>
<circle cx="60" cy="415" r="8" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="425" fill="white">Tunisia</text>
<circle cx="60" cy="445" r="8" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="455" fill="white">Senegal</text>
<circle cx="60" cy="475" r="8" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="485" fill="white">Burkina Faso</text>
<circle cx="280" cy="205" r="8" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="215" fill="white">Morocco</text>
<circle cx="280" cy="235" r="8" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="245" fill="white">Cote dIvoire</text>
<circle cx="280" cy="265" r="8" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="275" fill="white">Equator. Guinea</text>
<circle cx="280" cy="295" r="8" style="fill:#b2df8a;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="305" fill="white">Zimbabwe</text>
<circle cx="280" cy="325" r="8" style="fill:#CC00FF;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="335" fill="white">Cameroon</text>
<circle cx="280" cy="355" r="8" style="fill:#cab2d6;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="365" fill="white">Mali</text>
<circle cx="280" cy="385" r="8" style="fill:#b15928;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="395" fill="white">Algeria</text>
<circle cx="280" cy="415" r="8" style="fill:#ffffb3;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="425" fill="white">Kenya</text>
<circle cx="280" cy="445" r="8" style="fill:#fb8072;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="455" fill="white">Ghana</text>
<circle cx="280" cy="475" r="8" style="fill:#80b1d3;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="295" y="485" fill="white">SouthAfrica</text>
<circle cx="60" cy="530" r="1.20411998265592" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="101" cy="530" r="4" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="142" cy="530" r="8" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="183" cy="530" r="12" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="224" cy="530" r="16" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<text font-size="2.0em" x="50" y="575" fill="white">2      10        100        1k        10k</text>
<text font-size="2.0em" x="50" y="605" fill="white">genome samples</text>
<g>
	<title>2020-03-02 Algeria: 2 samples</title>
	<line x1="1217.7" y1="1190.6" x2="1219.6" y2="1189.6" style="stroke:#b15928;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-02  A23403G  Algeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="925.2" r="1.2" style="fill:#b15928;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-11 Senegal: 2 samples</title>
	<line x1="1218.9" y1="1193.5" x2="1220.9" y2="1192.8" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-11  A23403G  Senegal=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1009.4" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-12 Senegal: 2 samples</title>
	<line x1="1219.0" y1="1193.8" x2="1221.1" y2="1193.2" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-12  A23403G  Senegal=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1019.1" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-13 Senegal: 2 samples</title>
	<line x1="1219.1" y1="1194.2" x2="1221.2" y2="1193.5" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15 Morocco: 2 samples</title>
	<line x1="1219.3" y1="1194.8" x2="1221.4" y2="1194.3" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-15  A23403G  Morocco=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1048.5" r="1.2" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16 Tunisia: 2 samples</title>
	<line x1="1219.4" y1="1195.2" x2="1221.5" y2="1194.6" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16 Zambia: 2 samples</title>
	<line x1="1221.5" y1="1194.6" x2="1223.6" y2="1194.1" style="stroke:#B03060;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-16  A23403G  Zambia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="1.2" style="fill:#B03060;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-16  A23403G  Zambia=2 [100.0%] Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1058.4" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17 DRC: 6 samples</title>
	<line x1="1219.5" y1="1195.5" x2="1223.2" y2="1194.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17 Senegal: 2 samples</title>
	<line x1="1223.2" y1="1194.6" x2="1225.3" y2="1194.2" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17 Benin: 4 samples</title>
	<line x1="1225.3" y1="1194.2" x2="1228.3" y2="1193.5" style="stroke:#fdb462;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-17  A23403G  DRC=5 [83.3%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1068.3" r="2.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-17  A23403G  Benin=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1068.3" r="1.9" style="fill:#fdb462;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18 DRC: 5 samples</title>
	<line x1="1219.6" y1="1195.8" x2="1223.0" y2="1195.1" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18 Egypt: 2 samples</title>
	<line x1="1223.0" y1="1195.1" x2="1225.1" y2="1194.7" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18 Tunisia: 2 samples</title>
	<line x1="1225.1" y1="1194.7" x2="1227.2" y2="1194.2" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-18  A23403G  DRC=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1078.3" r="2.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-18  A23403G  DRC=5 [100.0%] Egypt=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1772.5" cy="1078.3" r="1.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-19 DRC: 2 samples</title>
	<line x1="1219.6" y1="1196.2" x2="1221.7" y2="1195.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-19  A23403G  DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1774.5" cy="1088.3" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20 DRC: 2 samples</title>
	<line x1="1219.7" y1="1196.5" x2="1221.8" y2="1196.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20 Senegal: 4 samples</title>
	<line x1="1221.8" y1="1196.2" x2="1224.9" y2="1195.6" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20 Morocco: 3 samples</title>
	<line x1="1224.9" y1="1195.6" x2="1227.6" y2="1195.1" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-20  A23403G  Morocco=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="1.9" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-20  A23403G  Senegal=2 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1098.4" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-21 DRC: 3 samples</title>
	<line x1="1219.8" y1="1196.9" x2="1222.4" y2="1196.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-21  A23403G  DRC=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1108.4" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-22 DRC: 7 samples</title>
	<line x1="1219.8" y1="1197.2" x2="1223.8" y2="1196.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22 Uganda: 2 samples</title>
	<line x1="1223.8" y1="1196.7" x2="1226.0" y2="1196.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-22  A23403G  DRC=6 [85.7%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1118.5" r="3.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24 Tunisia: 3 samples</title>
	<line x1="1219.9" y1="1197.9" x2="1222.6" y2="1197.6" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24 Reunion: 3 samples</title>
	<line x1="1222.6" y1="1197.6" x2="1225.3" y2="1197.3" style="stroke:#FF00FF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-24  A23403G  Reunion=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="1.9" style="fill:#FF00FF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-24  A23403G  Tunisia=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1138.8" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-25 DRC: 2 samples</title>
	<line x1="1219.9" y1="1198.3" x2="1222.1" y2="1198.1" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25 Uganda: 3 samples</title>
	<line x1="1222.1" y1="1198.1" x2="1224.8" y2="1197.8" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25 Nigeria: 2 samples</title>
	<line x1="1224.8" y1="1197.8" x2="1226.9" y2="1197.6" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-25  A23403G  DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1149.0" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-26 DRC: 4 samples</title>
	<line x1="1220.0" y1="1198.6" x2="1223.1" y2="1198.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26 Uganda: 2 samples</title>
	<line x1="1223.1" y1="1198.4" x2="1225.2" y2="1198.2" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26 Madagascar: 2 samples</title>
	<line x1="1225.2" y1="1198.2" x2="1227.4" y2="1198.1" style="stroke:#d9d9d9;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-26  A23403G  DRC=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1159.2" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27 South Africa: 5 samples</title>
	<line x1="1220.0" y1="1199.0" x2="1223.5" y2="1198.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27 Uganda: 3 samples</title>
	<line x1="1223.5" y1="1198.8" x2="1226.2" y2="1198.6" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27 Nigeria: 2 samples</title>
	<line x1="1226.2" y1="1198.6" x2="1228.3" y2="1198.5" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27 Ghana: 2 samples</title>
	<line x1="1228.3" y1="1198.5" x2="1230.5" y2="1198.4" style="stroke:#fb8072;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27 Gabon: 3 samples</title>
	<line x1="1230.5" y1="1198.4" x2="1233.2" y2="1198.3" style="stroke:#FAF0E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-27  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1169.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  A23403G  Uganda=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1169.4" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-27  A23403G  Uganda=2 [66.7%] Gabon=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1169.4" r="1.2" style="fill:#FAF0E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-29 Nigeria: 6 samples</title>
	<line x1="1220.0" y1="1199.7" x2="1223.8" y2="1199.6" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-30 Uganda: 5 samples</title>
	<line x1="1220.0" y1="1200.0" x2="1223.5" y2="1200.0" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-30 Morocco: 3 samples</title>
	<line x1="1223.5" y1="1200.0" x2="1226.2" y2="1200.0" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-30  A23403G  Uganda=3 [60.0%]  surface glycoprotein, D614G</title>
	<circle cx="1785.3" cy="1200.0" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-30  A23403G  Uganda=3 [60.0%] Morocco=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1785.3" cy="1200.0" r="1.9" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31 South Africa: 4 samples</title>
	<line x1="1220.0" y1="1200.3" x2="1223.1" y2="1200.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-31 Tunisia: 2 samples</title>
	<line x1="1223.1" y1="1200.4" x2="1225.3" y2="1200.4" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-31 Senegal: 2 samples</title>
	<line x1="1225.3" y1="1200.4" x2="1227.4" y2="1200.5" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-03-31  A23403G  South Africa=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1210.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-03-31  A23403G  South Africa=3 [75.0%] Senegal=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1785.2" cy="1210.2" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01 South Africa: 15 samples</title>
	<line x1="1220.0" y1="1200.7" x2="1225.4" y2="1200.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01 SaudiArabia: 19 samples</title>
	<line x1="1225.4" y1="1200.9" x2="1231.3" y2="1201.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01 Tunisia: 2 samples</title>
	<line x1="1231.3" y1="1201.1" x2="1233.4" y2="1201.2" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01 Zimbabwe: 4 samples</title>
	<line x1="1233.4" y1="1201.2" x2="1236.5" y2="1201.3" style="stroke:#b2df8a;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-01  G21624A  Zimbabwe=3 [75.0%]  surface glycoprotein, R21K</title>
	<circle cx="1389.0" cy="1206.6" r="1.9" style="fill:#b2df8a;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  South Africa=14 [93.3%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  SaudiArabia=12 [63.2%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="4.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  SaudiArabia=12 [63.2%] Zimbabwe=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="2.4" style="fill:#b2df8a;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-01  A23403G  SaudiArabia=12 [63.2%] Zimbabwe=4 [100.0%] Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1784.9" cy="1220.4" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02 South Africa: 2 samples</title>
	<line x1="1220.0" y1="1201.0" x2="1222.1" y2="1201.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-02 SaudiArabia: 5 samples</title>
	<line x1="1222.1" y1="1201.2" x2="1225.6" y2="1201.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-02  A23403G  SaudiArabia=3 [60.0%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1230.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-02  A23403G  SaudiArabia=3 [60.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1784.5" cy="1230.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-03 South Africa: 5 samples</title>
	<line x1="1220.0" y1="1201.4" x2="1223.4" y2="1201.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-03 Sierra Leone: 2 samples</title>
	<line x1="1223.4" y1="1201.6" x2="1225.6" y2="1201.8" style="stroke:#b3de69;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-03  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.9" cy="1240.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-04 South Africa: 4 samples</title>
	<line x1="1219.9" y1="1201.7" x2="1223.1" y2="1202.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-04  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1783.1" cy="1251.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-05 South Africa: 4 samples</title>
	<line x1="1219.9" y1="1202.1" x2="1223.0" y2="1202.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-05 DRC: 2 samples</title>
	<line x1="1223.0" y1="1202.4" x2="1225.2" y2="1202.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-05  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1782.1" cy="1261.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06 SaudiArabia: 22 samples</title>
	<line x1="1219.9" y1="1202.4" x2="1225.9" y2="1203.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06 DRC: 2 samples</title>
	<line x1="1225.9" y1="1203.2" x2="1228.1" y2="1203.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06 Mali: 4 samples</title>
	<line x1="1228.1" y1="1203.4" x2="1231.2" y2="1203.8" style="stroke:#cab2d6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-06  G21641T  SaudiArabia=2 [9.1%]  surface glycoprotein, A27S</title>
	<circle cx="1391.4" cy="1223.5" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  A23403G  SaudiArabia=13 [59.1%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1271.3" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-06  A23403G  SaudiArabia=13 [59.1%] DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1780.9" cy="1271.3" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-07 DRC: 5 samples</title>
	<line x1="1219.8" y1="1202.8" x2="1223.3" y2="1203.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-07  A23403G  DRC=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1779.6" cy="1281.5" r="2.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08 South Africa: 11 samples</title>
	<line x1="1219.8" y1="1203.1" x2="1224.6" y2="1203.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-08 SaudiArabia: 3 samples</title>
	<line x1="1224.6" y1="1203.9" x2="1227.2" y2="1204.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-08  A23403G  South Africa=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1291.6" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-08  A23403G  South Africa=11 [100.0%] SaudiArabia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1778.1" cy="1291.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09 South Africa: 6 samples</title>
	<line x1="1219.7" y1="1203.5" x2="1223.4" y2="1204.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09 SaudiArabia: 5 samples</title>
	<line x1="1223.4" y1="1204.1" x2="1226.9" y2="1204.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09 Nigeria: 2 samples</title>
	<line x1="1226.9" y1="1204.7" x2="1229.0" y2="1205.1" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09 Mali: 2 samples</title>
	<line x1="1229.0" y1="1205.1" x2="1231.1" y2="1205.5" style="stroke:#cab2d6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-09  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1301.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  A23403G  South Africa=6 [100.0%] SaudiArabia=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1301.6" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-09  A23403G  South Africa=6 [100.0%] SaudiArabia=5 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1776.4" cy="1301.6" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-10 Mali: 4 samples</title>
	<line x1="1219.6" y1="1203.8" x2="1222.7" y2="1204.4" style="stroke:#cab2d6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-10 Sierra Leone: 2 samples</title>
	<line x1="1222.7" y1="1204.4" x2="1224.8" y2="1204.8" style="stroke:#b3de69;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-12 SaudiArabia: 3 samples</title>
	<line x1="1219.5" y1="1204.5" x2="1222.1" y2="1205.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-12 Mali: 5 samples</title>
	<line x1="1222.1" y1="1205.1" x2="1225.5" y2="1205.9" style="stroke:#cab2d6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-12  A23403G  SaudiArabia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1331.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-12  A23403G  Mali=2 [40.0%]  surface glycoprotein, D614G</title>
	<circle cx="1770.3" cy="1331.7" r="1.2" style="fill:#cab2d6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-13 Morocco: 2 samples</title>
	<line x1="1219.4" y1="1204.8" x2="1221.5" y2="1205.4" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-13  A23403G  Morocco=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1767.9" cy="1341.6" r="1.2" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14 DRC: 2 samples</title>
	<line x1="1219.3" y1="1205.2" x2="1221.4" y2="1205.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-14 Mali: 4 samples</title>
	<line x1="1221.4" y1="1205.7" x2="1224.4" y2="1206.5" style="stroke:#cab2d6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-14  A23403G  DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1351.5" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-14  A23403G  Mali=2 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1765.4" cy="1351.5" r="1.2" style="fill:#cab2d6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15 South Africa: 2 samples</title>
	<line x1="1219.2" y1="1205.5" x2="1221.3" y2="1206.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15 SaudiArabia: 9 samples</title>
	<line x1="1221.3" y1="1206.1" x2="1225.6" y2="1207.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15 DRC: 6 samples</title>
	<line x1="1225.6" y1="1207.3" x2="1229.3" y2="1208.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15 Benin: 2 samples</title>
	<line x1="1229.3" y1="1208.4" x2="1231.3" y2="1209.0" style="stroke:#fdb462;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-15  A23403G  SaudiArabia=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  A23403G  SaudiArabia=9 [100.0%] DRC=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="3.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-15  A23403G  SaudiArabia=9 [100.0%] DRC=6 [100.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1762.6" cy="1361.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16 SaudiArabia: 4 samples</title>
	<line x1="1219.1" y1="1205.8" x2="1222.1" y2="1206.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-16 DRC: 4 samples</title>
	<line x1="1222.1" y1="1206.8" x2="1225.1" y2="1207.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-16  A23403G  DRC=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1371.1" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-16  A23403G  DRC=4 [100.0%] SaudiArabia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1759.7" cy="1371.1" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17 DRC: 2 samples</title>
	<line x1="1219.0" y1="1206.2" x2="1221.1" y2="1206.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-17 Senegal: 2 samples</title>
	<line x1="1221.1" y1="1206.8" x2="1223.1" y2="1207.5" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-17  A23403G  DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1380.9" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-17  A23403G  DRC=2 [100.0%] Senegal=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1756.7" cy="1380.9" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18 SaudiArabia: 12 samples</title>
	<line x1="1218.9" y1="1206.5" x2="1223.7" y2="1208.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-18 DRC: 2 samples</title>
	<line x1="1223.7" y1="1208.1" x2="1225.7" y2="1208.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-18 Senegal: 3 samples</title>
	<line x1="1225.7" y1="1208.8" x2="1228.2" y2="1209.7" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-18  A23403G  SaudiArabia=4 [33.3%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1390.6" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  A23403G  SaudiArabia=4 [33.3%] Senegal=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1390.6" r="1.9" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-18  A23403G  SaudiArabia=4 [33.3%] Senegal=3 [100.0%] DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1753.4" cy="1390.6" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-19 Morocco: 6 samples</title>
	<line x1="1218.8" y1="1206.8" x2="1222.4" y2="1208.1" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-19  A23403G  Morocco=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1750.0" cy="1400.2" r="3.1" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20 SaudiArabia: 3 samples</title>
	<line x1="1218.7" y1="1207.2" x2="1221.2" y2="1208.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-20 Nigeria: 4 samples</title>
	<line x1="1221.2" y1="1208.1" x2="1224.1" y2="1209.3" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-20  A23403G  Nigeria=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="1409.8" r="2.4" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-20  A23403G  Nigeria=4 [100.0%] SaudiArabia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1746.4" cy="1409.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21 South Africa: 2 samples</title>
	<line x1="1218.5" y1="1207.5" x2="1220.5" y2="1208.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21 SaudiArabia: 21 samples</title>
	<line x1="1220.5" y1="1208.3" x2="1226.1" y2="1210.6" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21 Senegal: 5 samples</title>
	<line x1="1226.1" y1="1210.6" x2="1229.4" y2="1211.9" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21 Morocco: 2 samples</title>
	<line x1="1229.4" y1="1211.9" x2="1231.4" y2="1212.7" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-21  A23403G  SaudiArabia=20 [95.2%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="5.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  A23403G  SaudiArabia=20 [95.2%] Senegal=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="2.8" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  A23403G  SaudiArabia=20 [95.2%] Senegal=5 [100.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-21  A23403G  SaudiArabia=20 [95.2%] Senegal=5 [100.0%] South Africa=2 [100.0%] Morocco=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1742.7" cy="1419.3" r="1.2" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-22 DRC: 3 samples</title>
	<line x1="1218.4" y1="1207.8" x2="1220.9" y2="1208.9" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-22  A23403G  DRC=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1738.8" cy="1428.7" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23 SaudiArabia: 25 samples</title>
	<line x1="1218.3" y1="1208.1" x2="1224.1" y2="1210.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23 DRC: 7 samples</title>
	<line x1="1224.1" y1="1210.7" x2="1227.8" y2="1212.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23 Nigeria: 4 samples</title>
	<line x1="1227.8" y1="1212.4" x2="1230.7" y2="1213.7" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23 Senegal: 3 samples</title>
	<line x1="1230.7" y1="1213.7" x2="1233.1" y2="1214.8" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-23  A23403G  SaudiArabia=22 [88.0%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="5.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  A23403G  SaudiArabia=22 [88.0%] DRC=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="3.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  A23403G  Nigeria=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="1.9" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-23  A23403G  Nigeria=3 [75.0%] Senegal=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1734.7" cy="1438.1" r="1.9" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24 SaudiArabia: 28 samples</title>
	<line x1="1218.1" y1="1208.5" x2="1224.1" y2="1211.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-24 DRC: 6 samples</title>
	<line x1="1224.1" y1="1211.2" x2="1227.5" y2="1212.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-24 Nigeria: 2 samples</title>
	<line x1="1227.5" y1="1212.8" x2="1229.5" y2="1213.7" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-24 Equatorial Guinea: 2 samples</title>
	<line x1="1229.5" y1="1213.7" x2="1231.4" y2="1214.7" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-24  A23403G  SaudiArabia=24 [85.7%]  surface glycoprotein, D614G</title>
	<circle cx="1730.5" cy="1447.4" r="5.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  A23403G  SaudiArabia=24 [85.7%] DRC=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1730.5" cy="1447.4" r="3.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  A23403G  SaudiArabia=24 [85.7%] DRC=6 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1730.5" cy="1447.4" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-24  A23403G  SaudiArabia=24 [85.7%] DRC=6 [100.0%] Nigeria=2 [100.0%] Equatorial Guinea=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1730.5" cy="1447.4" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25 DRC: 8 samples</title>
	<line x1="1218.0" y1="1208.8" x2="1221.8" y2="1210.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-25 Nigeria: 5 samples</title>
	<line x1="1221.8" y1="1210.6" x2="1225.0" y2="1212.2" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-25 Senegal: 4 samples</title>
	<line x1="1225.0" y1="1212.2" x2="1227.8" y2="1213.6" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-25  A23403G  DRC=6 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="1456.6" r="3.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25  A23403G  DRC=6 [75.0%] Nigeria=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="1456.6" r="2.8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-25  A23403G  DRC=6 [75.0%] Nigeria=5 [100.0%] Senegal=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1726.1" cy="1456.6" r="2.4" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26 South Africa: 2 samples</title>
	<line x1="1217.8" y1="1209.1" x2="1219.7" y2="1210.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-26 DRC: 3 samples</title>
	<line x1="1219.7" y1="1210.1" x2="1222.1" y2="1211.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-26  A23403G  DRC=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1721.5" cy="1465.7" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-26  A23403G  DRC=3 [100.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1721.5" cy="1465.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27 DRC: 7 samples</title>
	<line x1="1217.7" y1="1209.4" x2="1221.2" y2="1211.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-27 Uganda: 2 samples</title>
	<line x1="1221.2" y1="1211.3" x2="1223.1" y2="1212.3" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-27 Nigeria: 3 samples</title>
	<line x1="1223.1" y1="1212.3" x2="1225.5" y2="1213.6" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-27  A23403G  DRC=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="1474.8" r="3.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  A23403G  DRC=7 [100.0%] Nigeria=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="1474.8" r="1.9" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-27  A23403G  DRC=7 [100.0%] Nigeria=3 [100.0%] Uganda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1716.8" cy="1474.8" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28 SaudiArabia: 2 samples</title>
	<line x1="1217.5" y1="1209.7" x2="1219.4" y2="1210.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-28 DRC: 5 samples</title>
	<line x1="1219.4" y1="1210.7" x2="1222.4" y2="1212.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-28  A23403G  DRC=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="1483.8" r="2.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-28  A23403G  DRC=5 [100.0%] SaudiArabia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1711.9" cy="1483.8" r="1.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29 South Africa: 5 samples</title>
	<line x1="1217.3" y1="1210.0" x2="1220.4" y2="1211.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29 SaudiArabia: 3 samples</title>
	<line x1="1220.4" y1="1211.8" x2="1222.7" y2="1213.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29 DRC: 2 samples</title>
	<line x1="1222.7" y1="1213.1" x2="1224.6" y2="1214.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-29  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A23403G  South Africa=5 [100.0%] SaudiArabia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  A23403G  South Africa=5 [100.0%] SaudiArabia=3 [100.0%] DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1706.9" cy="1492.7" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  C24099T  South Africa=2 [40.0%]  surface glycoprotein, A846V</title>
	<circle cx="1841.1" cy="1570.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-29  G24197T  DRC=2 [100.0%]  surface glycoprotein, A879S</title>
	<circle cx="1860.0" cy="1581.1" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30 South Africa: 7 samples</title>
	<line x1="1217.1" y1="1210.3" x2="1220.6" y2="1212.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30 SaudiArabia: 7 samples</title>
	<line x1="1220.6" y1="1212.4" x2="1224.1" y2="1214.5" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30 Gambia: 2 samples</title>
	<line x1="1224.1" y1="1214.5" x2="1226.0" y2="1215.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30 DRC: 14 samples</title>
	<line x1="1226.0" y1="1215.6" x2="1230.5" y2="1218.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30 Egypt: 4 samples</title>
	<line x1="1230.5" y1="1218.3" x2="1233.2" y2="1219.9" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30 Equatorial Guinea: 2 samples</title>
	<line x1="1233.2" y1="1219.9" x2="1235.0" y2="1221.0" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-04-30  A23403G  DRC=13 [92.9%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="4.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A23403G  DRC=13 [92.9%] South Africa=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A23403G  SaudiArabia=5 [71.4%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A23403G  SaudiArabia=5 [71.4%] Egypt=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="1.9" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A23403G  SaudiArabia=5 [71.4%] Egypt=3 [75.0%] Gambia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  A23403G  SaudiArabia=5 [71.4%] Egypt=3 [75.0%] Gambia=2 [100.0%] Equatorial Guinea=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1701.7" cy="1501.5" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-04-30  G24197T  DRC=6 [42.9%]  surface glycoprotein, A879S</title>
	<circle cx="1853.3" cy="1592.5" r="3.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01 Uganda: 3 samples</title>
	<line x1="1217.0" y1="1210.6" x2="1219.3" y2="1212.0" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-01 Zimbabwe: 20 samples</title>
	<line x1="1219.3" y1="1212.0" x2="1224.3" y2="1215.2" style="stroke:#b2df8a;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-01  A23403G  Zimbabwe=20 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1696.4" cy="1510.2" r="5.2" style="fill:#b2df8a;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-01  A23403G  Zimbabwe=20 [100.0%] Uganda=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1696.4" cy="1510.2" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-02 Uganda: 2 samples</title>
	<line x1="1216.8" y1="1210.9" x2="1218.6" y2="1212.1" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-02 Egypt: 21 samples</title>
	<line x1="1218.6" y1="1212.1" x2="1223.6" y2="1215.4" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-02  A23403G  Egypt=20 [95.2%]  surface glycoprotein, D614G</title>
	<circle cx="1690.9" cy="1518.8" r="5.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-03 DRC: 2 samples</title>
	<line x1="1216.6" y1="1211.2" x2="1218.4" y2="1212.4" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-03  A23403G  DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1685.2" cy="1527.3" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04 South Africa: 4 samples</title>
	<line x1="1216.4" y1="1211.5" x2="1219.0" y2="1213.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-04 DRC: 3 samples</title>
	<line x1="1219.0" y1="1213.3" x2="1221.2" y2="1214.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-04 Uganda: 2 samples</title>
	<line x1="1221.2" y1="1214.8" x2="1222.9" y2="1216.1" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-04 Nigeria: 2 samples</title>
	<line x1="1222.9" y1="1216.1" x2="1224.7" y2="1217.3" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-04  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1679.5" cy="1535.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  A23403G  South Africa=4 [100.0%] DRC=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1679.5" cy="1535.7" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  A23403G  South Africa=4 [100.0%] DRC=3 [100.0%] Uganda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1679.5" cy="1535.7" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-04  A23403G  South Africa=4 [100.0%] DRC=3 [100.0%] Uganda=2 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1679.5" cy="1535.7" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05 South Africa: 5 samples</title>
	<line x1="1216.2" y1="1211.8" x2="1219.0" y2="1213.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-05 Egypt: 3 samples</title>
	<line x1="1219.0" y1="1213.8" x2="1221.2" y2="1215.4" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-05  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1673.5" cy="1544.0" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-05  A23403G  South Africa=5 [100.0%] Egypt=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1673.5" cy="1544.0" r="1.9" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06 South Africa: 2 samples</title>
	<line x1="1216.0" y1="1212.0" x2="1217.7" y2="1213.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-06 SaudiArabia: 4 samples</title>
	<line x1="1217.7" y1="1213.3" x2="1220.2" y2="1215.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-06  A23403G  SaudiArabia=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1667.4" cy="1552.2" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-06  A23403G  SaudiArabia=3 [75.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1667.4" cy="1552.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07 South Africa: 2 samples</title>
	<line x1="1215.8" y1="1212.3" x2="1217.5" y2="1213.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-07 DRC: 6 samples</title>
	<line x1="1217.5" y1="1213.6" x2="1220.4" y2="1216.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-07 Uganda: 9 samples</title>
	<line x1="1220.4" y1="1216.0" x2="1224.0" y2="1218.7" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-07  A23403G  DRC=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1661.2" cy="1560.3" r="3.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  A23403G  Uganda=5 [55.6%]  surface glycoprotein, D614G</title>
	<circle cx="1661.2" cy="1560.3" r="2.8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  A23403G  Uganda=5 [55.6%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1661.2" cy="1560.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G24368T  Uganda=2 [22.2%]  surface glycoprotein, D936Y</title>
	<circle cx="1830.6" cy="1692.7" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-07  G24893C  Uganda=2 [22.2%]  surface glycoprotein, E1111Q</title>
	<circle cx="1922.7" cy="1764.7" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08 South Africa: 2 samples</title>
	<line x1="1215.5" y1="1212.6" x2="1217.2" y2="1213.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-08 SaudiArabia: 4 samples</title>
	<line x1="1217.2" y1="1213.9" x2="1219.7" y2="1215.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-08 Nigeria: 2 samples</title>
	<line x1="1219.7" y1="1215.9" x2="1221.3" y2="1217.3" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-08  A23403G  SaudiArabia=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1654.9" cy="1568.3" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-08  A23403G  SaudiArabia=3 [75.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1654.9" cy="1568.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-09 Nigeria: 2 samples</title>
	<line x1="1215.3" y1="1212.9" x2="1217.0" y2="1214.2" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-09  A23403G  Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1648.4" cy="1576.2" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-10 South Africa: 2 samples</title>
	<line x1="1215.1" y1="1213.1" x2="1216.7" y2="1214.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-10 Egypt: 3 samples</title>
	<line x1="1216.7" y1="1214.5" x2="1218.8" y2="1216.3" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-10  A23403G  Egypt=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1641.7" cy="1584.0" r="1.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-10  A23403G  Egypt=2 [66.7%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1641.7" cy="1584.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11 DRC: 4 samples</title>
	<line x1="1214.9" y1="1213.4" x2="1217.2" y2="1215.5" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-11 Nigeria: 2 samples</title>
	<line x1="1217.2" y1="1215.5" x2="1218.8" y2="1216.9" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-11 Egypt: 4 samples</title>
	<line x1="1218.8" y1="1216.9" x2="1221.1" y2="1219.0" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-11  C23127T  Nigeria=2 [100.0%]  surface glycoprotein, A522V</title>
	<circle cx="1589.3" cy="1550.5" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A23403G  Egypt=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1635.0" cy="1591.6" r="2.4" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A23403G  Egypt=4 [100.0%] DRC=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1635.0" cy="1591.6" r="2.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-11  A23403G  Egypt=4 [100.0%] DRC=4 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1635.0" cy="1591.6" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12 SaudiArabia: 7 samples</title>
	<line x1="1214.6" y1="1213.6" x2="1217.6" y2="1216.4" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-12 DRC: 2 samples</title>
	<line x1="1217.6" y1="1216.4" x2="1219.2" y2="1217.9" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-12  A23403G  SaudiArabia=5 [71.4%]  surface glycoprotein, D614G</title>
	<circle cx="1628.1" cy="1599.2" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-12  A23403G  SaudiArabia=5 [71.4%] DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1628.1" cy="1599.2" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13 South Africa: 11 samples</title>
	<line x1="1214.4" y1="1213.9" x2="1217.9" y2="1217.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-13 Egypt: 3 samples</title>
	<line x1="1217.9" y1="1217.3" x2="1219.8" y2="1219.1" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-13  A23403G  South Africa=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1621.0" cy="1606.6" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-13  A23403G  South Africa=11 [100.0%] Egypt=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1621.0" cy="1606.6" r="1.9" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14 South Africa: 8 samples</title>
	<line x1="1214.1" y1="1214.1" x2="1217.2" y2="1217.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-14 Nigeria: 5 samples</title>
	<line x1="1217.2" y1="1217.2" x2="1219.7" y2="1219.7" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-14  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1613.9" cy="1613.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-14  A23403G  Nigeria=4 [80.0%]  surface glycoprotein, D614G</title>
	<circle cx="1613.9" cy="1613.9" r="2.4" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-16 Nigeria: 5 samples</title>
	<line x1="1213.6" y1="1214.6" x2="1216.0" y2="1217.2" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-16  A23403G  Nigeria=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1599.2" cy="1628.1" r="2.8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-18 Nigeria: 2 samples</title>
	<line x1="1213.1" y1="1215.1" x2="1214.5" y2="1216.7" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19 South Africa: 3 samples</title>
	<line x1="1212.9" y1="1215.3" x2="1214.6" y2="1217.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19 Equatorial Guinea: 2 samples</title>
	<line x1="1214.6" y1="1217.4" x2="1216.0" y2="1219.0" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-19  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1576.2" cy="1648.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-19  A23403G  South Africa=3 [100.0%] Equatorial Guinea=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1576.2" cy="1648.4" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20 South Africa: 2 samples</title>
	<line x1="1212.6" y1="1215.5" x2="1213.9" y2="1217.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20 DRC: 3 samples</title>
	<line x1="1213.9" y1="1217.2" x2="1215.6" y2="1219.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20 Equatorial Guinea: 2 samples</title>
	<line x1="1215.6" y1="1219.3" x2="1217.0" y2="1221.0" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20 Ghana: 2 samples</title>
	<line x1="1217.0" y1="1221.0" x2="1218.3" y2="1222.7" style="stroke:#fb8072;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-20  A23403G  DRC=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1568.3" cy="1654.9" r="1.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  A23403G  DRC=3 [100.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1568.3" cy="1654.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-20  A23403G  DRC=3 [100.0%] South Africa=2 [100.0%] Equatorial Guinea=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1568.3" cy="1654.9" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21 South Africa: 3 samples</title>
	<line x1="1212.3" y1="1215.8" x2="1214.0" y2="1217.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-21 DRC: 2 samples</title>
	<line x1="1214.0" y1="1217.9" x2="1215.3" y2="1219.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-21  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1560.3" cy="1661.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-21  A23403G  South Africa=3 [100.0%] DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1560.3" cy="1661.2" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22 DRC: 7 samples</title>
	<line x1="1212.0" y1="1216.0" x2="1214.5" y2="1219.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-22 Nigeria: 2 samples</title>
	<line x1="1214.5" y1="1219.2" x2="1215.8" y2="1220.9" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-22  A23403G  DRC=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1552.2" cy="1667.4" r="3.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-22  A23403G  DRC=7 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1552.2" cy="1667.4" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-23 DRC: 2 samples</title>
	<line x1="1211.8" y1="1216.2" x2="1213.0" y2="1217.9" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-23  A23403G  DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1544.0" cy="1673.5" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24 South Africa: 3 samples</title>
	<line x1="1211.5" y1="1216.4" x2="1213.0" y2="1218.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-24 SaudiArabia: 35 samples</title>
	<line x1="1213.0" y1="1218.6" x2="1217.0" y2="1224.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-24 DRC: 7 samples</title>
	<line x1="1217.0" y1="1224.3" x2="1219.4" y2="1227.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-24 Ghana: 2 samples</title>
	<line x1="1219.4" y1="1227.7" x2="1220.6" y2="1229.4" style="stroke:#fb8072;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-24  A23403G  SaudiArabia=13 [37.1%]  surface glycoprotein, D614G</title>
	<circle cx="1535.7" cy="1679.5" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24  A23403G  SaudiArabia=13 [37.1%] DRC=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1535.7" cy="1679.5" r="3.4" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-24  A23403G  SaudiArabia=13 [37.1%] DRC=7 [100.0%] South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1535.7" cy="1679.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-25 South Africa: 2 samples</title>
	<line x1="1211.2" y1="1216.6" x2="1212.4" y2="1218.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25 DRC: 12 samples</title>
	<line x1="1212.4" y1="1218.4" x2="1215.2" y2="1222.5" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25 Ghana: 4 samples</title>
	<line x1="1215.2" y1="1222.5" x2="1216.9" y2="1225.1" style="stroke:#fb8072;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-25  A23403G  DRC=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1527.3" cy="1685.2" r="4.3" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-25  A23403G  Ghana=3 [75.0%]  surface glycoprotein, D614G</title>
	<circle cx="1527.3" cy="1685.2" r="1.9" style="fill:#fb8072;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-25  A23403G  Ghana=3 [75.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1527.3" cy="1685.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26 SaudiArabia: 14 samples</title>
	<line x1="1210.9" y1="1216.8" x2="1213.8" y2="1221.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-26 DRC: 2 samples</title>
	<line x1="1213.8" y1="1221.2" x2="1214.9" y2="1223.0" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-26  A23403G  SaudiArabia=7 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1518.8" cy="1690.9" r="3.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-26  A23403G  SaudiArabia=7 [50.0%] DRC=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1518.8" cy="1690.9" r="1.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-27 SaudiArabia: 2 samples</title>
	<line x1="1210.6" y1="1217.0" x2="1211.7" y2="1218.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-27 Equatorial Guinea: 2 samples</title>
	<line x1="1211.7" y1="1218.8" x2="1212.9" y2="1220.6" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-27  A23403G  Equatorial Guinea=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1510.2" cy="1696.4" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-28 South Africa: 2 samples</title>
	<line x1="1210.3" y1="1217.1" x2="1211.4" y2="1219.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-28  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1501.5" cy="1701.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30 South Africa: 7 samples</title>
	<line x1="1209.7" y1="1217.5" x2="1211.7" y2="1221.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-30 Equatorial Guinea: 3 samples</title>
	<line x1="1211.7" y1="1221.0" x2="1213.0" y2="1223.4" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-30  A23403G  South Africa=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1483.8" cy="1711.9" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-30  A23403G  South Africa=7 [100.0%] Equatorial Guinea=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1483.8" cy="1711.9" r="1.9" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-05-31 South Africa: 2 samples</title>
	<line x1="1209.4" y1="1217.7" x2="1210.4" y2="1219.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-05-31  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1474.8" cy="1716.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01 South Africa: 10 samples</title>
	<line x1="1209.1" y1="1217.8" x2="1211.2" y2="1222.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-01 Nigeria: 2 samples</title>
	<line x1="1211.2" y1="1222.0" x2="1212.2" y2="1223.9" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-01 Zimbabwe: 10 samples</title>
	<line x1="1212.2" y1="1223.9" x2="1214.3" y2="1228.1" style="stroke:#b2df8a;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-01  A23403G  South Africa=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1465.7" cy="1721.5" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  A23403G  South Africa=10 [100.0%] Zimbabwe=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1465.7" cy="1721.5" r="4.0" style="fill:#b2df8a;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  A23403G  South Africa=10 [100.0%] Zimbabwe=10 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1465.7" cy="1721.5" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-01  C23625T  South Africa=3 [30.0%]  surface glycoprotein, A688V</title>
	<circle cx="1488.2" cy="1765.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02 South Africa: 4 samples</title>
	<line x1="1208.8" y1="1218.0" x2="1210.1" y2="1220.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-02 Nigeria: 2 samples</title>
	<line x1="1210.1" y1="1220.8" x2="1211.1" y2="1222.7" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-02 Egypt: 52 samples</title>
	<line x1="1211.1" y1="1222.7" x2="1214.5" y2="1229.7" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-02  A23403G  Egypt=50 [96.2%]  surface glycoprotein, D614G</title>
	<circle cx="1456.6" cy="1726.1" r="6.8" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  A23403G  Egypt=50 [96.2%] South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1456.6" cy="1726.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  A23403G  Egypt=50 [96.2%] South Africa=4 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1456.6" cy="1726.1" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-02  G23593T  Egypt=8 [15.4%]  surface glycoprotein, Q677H</title>
	<circle cx="1475.1" cy="1764.1" r="3.6" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04 South Africa: 3 samples</title>
	<line x1="1208.1" y1="1218.3" x2="1209.2" y2="1220.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-04 Cote dIvoire: 2 samples</title>
	<line x1="1209.2" y1="1220.7" x2="1210.1" y2="1222.7" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-04  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1438.1" cy="1734.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-04  A23403G  South Africa=3 [100.0%] Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1438.1" cy="1734.7" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-05 South Africa: 2 samples</title>
	<line x1="1207.8" y1="1218.4" x2="1208.7" y2="1220.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-05  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1428.7" cy="1738.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06 South Africa: 3 samples</title>
	<line x1="1207.5" y1="1218.5" x2="1208.5" y2="1221.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-06 Congo: 2 samples</title>
	<line x1="1208.5" y1="1221.1" x2="1209.3" y2="1223.0" style="stroke:#fccde5;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-06  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1419.3" cy="1742.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-06  A23403G  South Africa=3 [100.0%] Congo=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1419.3" cy="1742.7" r="1.2" style="fill:#fccde5;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-07 Senegal: 3 samples</title>
	<line x1="1207.2" y1="1218.7" x2="1208.1" y2="1221.2" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-07  A23403G  Senegal=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1409.8" cy="1746.4" r="1.9" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-09 Guinea: 3 samples</title>
	<line x1="1206.5" y1="1218.9" x2="1207.4" y2="1221.5" style="stroke:#ffed6f;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-09  A23403G  Guinea=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1390.6" cy="1753.4" r="1.9" style="fill:#ffed6f;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10 Senegal: 2 samples</title>
	<line x1="1206.2" y1="1219.0" x2="1206.8" y2="1221.1" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-10 Cote dIvoire: 2 samples</title>
	<line x1="1206.8" y1="1221.1" x2="1207.5" y2="1223.1" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-10  A23403G  Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1380.9" cy="1756.7" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-10  A23403G  Cote dIvoire=2 [100.0%] Senegal=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1380.9" cy="1756.7" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11 South Africa: 9 samples</title>
	<line x1="1205.8" y1="1219.1" x2="1207.2" y2="1223.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11 SaudiArabia: 22 samples</title>
	<line x1="1207.2" y1="1223.4" x2="1209.0" y2="1229.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11 Nigeria: 3 samples</title>
	<line x1="1209.0" y1="1229.3" x2="1209.7" y2="1231.9" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11 Senegal: 4 samples</title>
	<line x1="1209.7" y1="1231.9" x2="1210.7" y2="1234.9" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-11  A23403G  South Africa=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23403G  SaudiArabia=9 [40.9%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23403G  SaudiArabia=9 [40.9%] Senegal=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="2.4" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  A23403G  Nigeria=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1371.1" cy="1759.7" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-11  C23625T  South Africa=9 [100.0%]  surface glycoprotein, A688V</title>
	<circle cx="1385.6" cy="1807.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12 Nigeria: 3 samples</title>
	<line x1="1205.5" y1="1219.2" x2="1206.3" y2="1221.8" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-12 Senegal: 6 samples</title>
	<line x1="1206.3" y1="1221.8" x2="1207.3" y2="1225.5" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-12 Cote dIvoire: 2 samples</title>
	<line x1="1207.3" y1="1225.5" x2="1207.9" y2="1227.5" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-12  G22346T  Nigeria=2 [66.7%]  surface glycoprotein, A262S</title>
	<circle cx="1296.4" cy="1536.3" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23403G  Senegal=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1361.3" cy="1762.6" r="3.1" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23403G  Senegal=6 [100.0%] Nigeria=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1361.3" cy="1762.6" r="1.9" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23403G  Senegal=6 [100.0%] Nigeria=3 [100.0%] Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1361.3" cy="1762.6" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-12  A23586G  Nigeria=2 [66.7%]  surface glycoprotein, Q675R</title>
	<circle cx="1372.6" cy="1801.8" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13 SaudiArabia: 20 samples</title>
	<line x1="1205.2" y1="1219.3" x2="1206.7" y2="1225.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-13 Nigeria: 4 samples</title>
	<line x1="1206.7" y1="1225.1" x2="1207.5" y2="1228.1" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-13 Senegal: 7 samples</title>
	<line x1="1207.5" y1="1228.1" x2="1208.6" y2="1232.0" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-13 Cote dIvoire: 2 samples</title>
	<line x1="1208.6" y1="1232.0" x2="1209.1" y2="1234.1" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-13  A23403G  SaudiArabia=10 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1351.5" cy="1765.4" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  A23403G  SaudiArabia=10 [50.0%] Senegal=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1351.5" cy="1765.4" r="3.4" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  A23403G  SaudiArabia=10 [50.0%] Senegal=7 [100.0%] Nigeria=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1351.5" cy="1765.4" r="2.4" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-13  A23403G  SaudiArabia=10 [50.0%] Senegal=7 [100.0%] Nigeria=4 [100.0%] Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1351.5" cy="1765.4" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-14 Senegal: 3 samples</title>
	<line x1="1204.8" y1="1219.4" x2="1205.5" y2="1222.0" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-14  A23403G  Senegal=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1341.6" cy="1767.9" r="1.9" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-15 Senegal: 2 samples</title>
	<line x1="1204.5" y1="1219.5" x2="1205.0" y2="1221.6" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-15  A23403G  Senegal=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1331.7" cy="1770.3" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16 Nigeria: 2 samples</title>
	<line x1="1204.2" y1="1219.6" x2="1204.6" y2="1221.7" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-16 Cote dIvoire: 3 samples</title>
	<line x1="1204.6" y1="1221.7" x2="1205.2" y2="1224.3" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-16  A23403G  Cote dIvoire=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="1772.5" r="1.9" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-16  A23403G  Cote dIvoire=3 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="1772.5" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17 South Africa: 3 samples</title>
	<line x1="1203.8" y1="1219.6" x2="1204.3" y2="1222.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17 SaudiArabia: 18 samples</title>
	<line x1="1204.3" y1="1222.3" x2="1205.4" y2="1227.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17 Nigeria: 2 samples</title>
	<line x1="1205.4" y1="1227.9" x2="1205.8" y2="1230.0" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17 Senegal: 3 samples</title>
	<line x1="1205.8" y1="1230.0" x2="1206.4" y2="1232.7" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-17  A23403G  SaudiArabia=8 [44.4%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23403G  SaudiArabia=8 [44.4%] South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23403G  SaudiArabia=8 [44.4%] South Africa=3 [100.0%] Senegal=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="1.9" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-17  A23403G  SaudiArabia=8 [44.4%] South Africa=3 [100.0%] Senegal=3 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="1774.5" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18 South Africa: 5 samples</title>
	<line x1="1203.5" y1="1219.7" x2="1204.1" y2="1223.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-18 Senegal: 2 samples</title>
	<line x1="1204.1" y1="1223.1" x2="1204.5" y2="1225.3" style="stroke:red;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-18  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="1776.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-18  A23403G  South Africa=5 [100.0%] Senegal=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="1776.4" r="1.2" style="fill:red;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19 South Africa: 2 samples</title>
	<line x1="1203.1" y1="1219.8" x2="1203.5" y2="1221.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19 Cote dIvoire: 3 samples</title>
	<line x1="1203.5" y1="1221.9" x2="1203.9" y2="1224.6" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19 Algeria: 2 samples</title>
	<line x1="1203.9" y1="1224.6" x2="1204.2" y2="1226.7" style="stroke:#b15928;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-19  A23403G  Cote dIvoire=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="1.9" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23403G  Cote dIvoire=3 [100.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-19  A23403G  Cote dIvoire=3 [100.0%] South Africa=2 [100.0%] Algeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="1778.1" r="1.2" style="fill:#b15928;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20 Cote dIvoire: 2 samples</title>
	<line x1="1202.8" y1="1219.8" x2="1203.1" y2="1221.9" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-20 Algeria: 2 samples</title>
	<line x1="1203.1" y1="1221.9" x2="1203.4" y2="1224.1" style="stroke:#b15928;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-20  A23403G  Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="1779.6" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-20  A23403G  Cote dIvoire=2 [100.0%] Algeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="1779.6" r="1.2" style="fill:#b15928;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-21 Burkina Faso: 4 samples</title>
	<line x1="1202.4" y1="1219.9" x2="1202.8" y2="1223.0" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-21  A23403G  Burkina Faso=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1271.3" cy="1780.9" r="2.4" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23 South Africa: 7 samples</title>
	<line x1="1201.7" y1="1219.9" x2="1202.1" y2="1224.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-23 SaudiArabia: 24 samples</title>
	<line x1="1202.1" y1="1224.0" x2="1202.6" y2="1230.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-23  A23403G  SaudiArabia=11 [45.8%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="1783.1" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-23  A23403G  SaudiArabia=11 [45.8%] South Africa=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="1783.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24 South Africa: 3 samples</title>
	<line x1="1201.4" y1="1220.0" x2="1201.6" y2="1222.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-24 Nigeria: 2 samples</title>
	<line x1="1201.6" y1="1222.7" x2="1201.7" y2="1224.8" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-24 Cote dIvoire: 2 samples</title>
	<line x1="1201.7" y1="1224.8" x2="1201.9" y2="1226.9" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-24  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="1783.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  A23403G  South Africa=3 [100.0%] Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="1783.9" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-24  A23403G  South Africa=3 [100.0%] Cote dIvoire=2 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="1783.9" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25 South Africa: 10 samples</title>
	<line x1="1201.0" y1="1220.0" x2="1201.3" y2="1224.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-25  A23403G  South Africa=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="1784.5" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-25  C23520T  South Africa=3 [30.0%]  surface glycoprotein, A653V</title>
	<circle cx="1232.0" cy="1810.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26 South Africa: 5 samples</title>
	<line x1="1200.7" y1="1220.0" x2="1200.8" y2="1223.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-26 Nigeria: 2 samples</title>
	<line x1="1200.8" y1="1223.5" x2="1200.9" y2="1225.6" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-26  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="1784.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  A23403G  South Africa=5 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="1784.9" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-26  C23520T  South Africa=3 [60.0%]  surface glycoprotein, A653V</title>
	<circle cx="1221.3" cy="1811.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-27 Nigeria: 3 samples</title>
	<line x1="1200.3" y1="1220.0" x2="1200.4" y2="1222.7" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-27  A23403G  Nigeria=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="1785.2" r="1.9" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29 South Africa: 5 samples</title>
	<line x1="1199.7" y1="1220.0" x2="1199.6" y2="1223.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-29 Nigeria: 3 samples</title>
	<line x1="1199.6" y1="1223.5" x2="1199.5" y2="1226.2" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-29 Cote dIvoire: 2 samples</title>
	<line x1="1199.5" y1="1226.2" x2="1199.5" y2="1228.4" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-29  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1785.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A23403G  South Africa=5 [100.0%] Nigeria=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1785.2" r="1.9" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  A23403G  South Africa=5 [100.0%] Nigeria=3 [100.0%] Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1189.8" cy="1785.2" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G23587C  Nigeria=2 [66.7%]  surface glycoprotein, Q675H</title>
	<circle cx="1189.1" cy="1826.2" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-29  G25455T  South Africa=2 [40.0%]  ORF3a protein, K21N</title>
	<circle cx="1181.8" cy="2242.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30 South Africa: 4 samples</title>
	<line x1="1199.3" y1="1220.0" x2="1199.2" y2="1223.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30 Gambia: 3 samples</title>
	<line x1="1199.2" y1="1223.1" x2="1199.1" y2="1225.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30 Nigeria: 2 samples</title>
	<line x1="1199.1" y1="1225.8" x2="1199.0" y2="1228.0" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-06-30  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23403G  South Africa=4 [100.0%] Gambia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-06-30  A23403G  South Africa=4 [100.0%] Gambia=3 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1179.6" cy="1784.9" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01 South Africa: 30 samples</title>
	<line x1="1199.0" y1="1220.0" x2="1198.6" y2="1226.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-01 Nigeria: 2 samples</title>
	<line x1="1198.6" y1="1226.7" x2="1198.5" y2="1228.8" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-01  A23403G  South Africa=30 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="1784.5" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  A23403G  South Africa=30 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1169.4" cy="1784.5" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-01  G25455T  South Africa=3 [10.0%]  ORF3a protein, K21N</title>
	<circle cx="1145.4" cy="2240.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02 South Africa: 27 samples</title>
	<line x1="1198.6" y1="1220.0" x2="1198.2" y2="1226.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02 Cote dIvoire: 2 samples</title>
	<line x1="1198.2" y1="1226.4" x2="1198.0" y2="1228.6" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02 Equatorial Guinea: 2 samples</title>
	<line x1="1198.0" y1="1228.6" x2="1197.9" y2="1230.7" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02 Kenya: 2 samples</title>
	<line x1="1197.9" y1="1230.7" x2="1197.7" y2="1232.9" style="stroke:#ffffb3;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-02  A23403G  South Africa=27 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  South Africa=27 [100.0%] Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  South Africa=27 [100.0%] Cote dIvoire=2 [100.0%] Kenya=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="1.2" style="fill:#ffffb3;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  A23403G  South Africa=27 [100.0%] Cote dIvoire=2 [100.0%] Kenya=2 [100.0%] Equatorial Guinea=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="1783.9" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-02  G25455T  South Africa=3 [11.1%]  ORF3a protein, K21N</title>
	<circle cx="1127.3" cy="2239.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03 South Africa: 18 samples</title>
	<line x1="1198.3" y1="1219.9" x2="1197.8" y2="1225.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-03  A23403G  South Africa=18 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1149.0" cy="1783.1" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-03  C24374A  South Africa=2 [11.1%]  surface glycoprotein, L938I</title>
	<circle cx="1130.1" cy="1998.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04 South Africa: 3 samples</title>
	<line x1="1197.9" y1="1219.9" x2="1197.6" y2="1222.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-04 Gambia: 2 samples</title>
	<line x1="1197.6" y1="1222.6" x2="1197.4" y2="1224.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-04 Uganda: 4 samples</title>
	<line x1="1197.4" y1="1224.7" x2="1197.1" y2="1227.8" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-04  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="1782.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  A23403G  Uganda=2 [50.0%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="1782.1" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-04  A23403G  Uganda=2 [50.0%] Gambia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1138.8" cy="1782.1" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-05 South Africa: 3 samples</title>
	<line x1="1197.6" y1="1219.9" x2="1197.2" y2="1222.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-05  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1128.7" cy="1780.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-06 South Africa: 5 samples</title>
	<line x1="1197.2" y1="1219.8" x2="1196.7" y2="1223.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-06  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1118.5" cy="1779.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07 South Africa: 15 samples</title>
	<line x1="1196.9" y1="1219.8" x2="1196.0" y2="1225.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-07 Nigeria: 3 samples</title>
	<line x1="1196.0" y1="1225.1" x2="1195.6" y2="1227.8" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-07  A23403G  South Africa=15 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1108.4" cy="1778.1" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  A23403G  South Africa=15 [100.0%] Nigeria=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1108.4" cy="1778.1" r="1.9" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-07  G25455T  South Africa=2 [13.3%]  ORF3a protein, K21N</title>
	<circle cx="1036.9" cy="2229.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08 South Africa: 13 samples</title>
	<line x1="1196.5" y1="1219.7" x2="1195.6" y2="1224.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-08 Nigeria: 3 samples</title>
	<line x1="1195.6" y1="1224.8" x2="1195.2" y2="1227.4" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-08  A23403G  South Africa=13 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="1776.4" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-08  A23403G  South Africa=13 [100.0%] Nigeria=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="1776.4" r="1.9" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09 South Africa: 19 samples</title>
	<line x1="1196.2" y1="1219.6" x2="1195.1" y2="1225.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-09  A23403G  South Africa=19 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="1774.5" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  G23868T  South Africa=3 [15.8%]  surface glycoprotein, G769V</title>
	<circle cx="1068.6" cy="1876.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-09  G24794T  South Africa=4 [21.1%]  surface glycoprotein, A1078S</title>
	<circle cx="1029.2" cy="2078.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10 South Africa: 20 samples</title>
	<line x1="1195.8" y1="1219.6" x2="1194.6" y2="1225.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-10 Nigeria: 2 samples</title>
	<line x1="1194.6" y1="1225.4" x2="1194.2" y2="1227.5" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-10  A23403G  South Africa=20 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="1772.5" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  A23403G  South Africa=20 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1078.3" cy="1772.5" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G23868T  South Africa=3 [15.0%]  surface glycoprotein, G769V</title>
	<circle cx="1056.8" cy="1873.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  G24794T  South Africa=3 [15.0%]  surface glycoprotein, A1078S</title>
	<circle cx="1013.9" cy="2075.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-10  C25350T  South Africa=3 [15.0%]  surface glycoprotein, P1263L</title>
	<circle cx="988.2" cy="2196.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-11 South Africa: 6 samples</title>
	<line x1="1195.5" y1="1219.5" x2="1194.6" y2="1223.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-11  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1068.3" cy="1770.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-12 South Africa: 3 samples</title>
	<line x1="1195.2" y1="1219.4" x2="1194.5" y2="1222.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-12 Nigeria: 2 samples</title>
	<line x1="1194.5" y1="1222.0" x2="1194.0" y2="1224.1" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-12  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1058.4" cy="1767.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-12  A23403G  South Africa=3 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1058.4" cy="1767.9" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13 South Africa: 57 samples</title>
	<line x1="1194.8" y1="1219.3" x2="1192.8" y2="1227.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-13  C22224T  South Africa=2 [3.5%]  surface glycoprotein, S221L</title>
	<circle cx="1116.5" cy="1511.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  A23403G  South Africa=57 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1048.5" cy="1765.4" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  G23868T  South Africa=2 [3.5%]  surface glycoprotein, G769V</title>
	<circle cx="1021.7" cy="1865.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-13  G25455T  South Africa=4 [7.0%]  ORF3a protein, K21N</title>
	<circle cx="930.2" cy="2206.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14 South Africa: 29 samples</title>
	<line x1="1194.5" y1="1219.2" x2="1192.7" y2="1225.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-14  G21586T  South Africa=2 [6.9%]  surface glycoprotein, L8F</title>
	<circle cx="1150.2" cy="1373.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  A23403G  South Africa=29 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1038.7" cy="1762.6" r="5.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-14  G24794T  South Africa=2 [6.9%]  surface glycoprotein, A1078S</title>
	<circle cx="953.3" cy="2060.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15 South Africa: 22 samples</title>
	<line x1="1194.2" y1="1219.1" x2="1192.4" y2="1225.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-15 Equatorial Guinea: 2 samples</title>
	<line x1="1192.4" y1="1225.0" x2="1191.7" y2="1227.0" style="stroke:#F08080;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-15  G22203T  South Africa=2 [9.1%]  surface glycoprotein, R214L</title>
	<circle cx="1107.0" cy="1504.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23403G  South Africa=22 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="1759.7" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  A23403G  South Africa=22 [100.0%] Equatorial Guinea=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1028.9" cy="1759.7" r="1.2" style="fill:#F08080;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-15  G23426T  South Africa=2 [9.1%]  surface glycoprotein, V622F</title>
	<circle cx="1027.4" cy="1764.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16 South Africa: 32 samples</title>
	<line x1="1193.8" y1="1219.0" x2="1191.7" y2="1225.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-16  A23403G  South Africa=32 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="1756.7" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-16  C23997T  South Africa=2 [6.2%]  surface glycoprotein, P812L</title>
	<circle cx="978.3" cy="1882.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17 South Africa: 26 samples</title>
	<line x1="1193.5" y1="1218.9" x2="1191.4" y2="1225.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-17 Cote dIvoire: 2 samples</title>
	<line x1="1191.4" y1="1225.0" x2="1190.7" y2="1227.0" style="stroke:#ADD8E6;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-17  A23403G  South Africa=26 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="1753.4" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  A23403G  South Africa=26 [100.0%] Cote dIvoire=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1009.4" cy="1753.4" r="1.2" style="fill:#ADD8E6;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-17  C23625T  South Africa=2 [7.7%]  surface glycoprotein, A688V</title>
	<circle cx="993.3" cy="1800.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18 South Africa: 38 samples</title>
	<line x1="1193.2" y1="1218.8" x2="1190.7" y2="1225.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-18  A23403G  South Africa=38 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="999.8" cy="1750.0" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-18  T25451C  South Africa=3 [7.9%]  ORF3a protein, I20T</title>
	<circle cx="843.8" cy="2178.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19 South Africa: 14 samples</title>
	<line x1="1192.8" y1="1218.7" x2="1190.9" y2="1223.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-19 Egypt: 10 samples</title>
	<line x1="1190.9" y1="1223.6" x2="1189.3" y2="1228.0" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-19  A23403G  South Africa=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="990.2" cy="1746.4" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-19  A23403G  Egypt=9 [90.0%]  surface glycoprotein, D614G</title>
	<circle cx="990.2" cy="1746.4" r="3.8" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20 South Africa: 13 samples</title>
	<line x1="1192.5" y1="1218.5" x2="1190.6" y2="1223.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-20 Nigeria: 2 samples</title>
	<line x1="1190.6" y1="1223.3" x2="1189.8" y2="1225.3" style="stroke:lime;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-20  A23403G  South Africa=13 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="1742.7" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-20  A23403G  South Africa=13 [100.0%] Nigeria=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="1742.7" r="1.2" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21 South Africa: 30 samples</title>
	<line x1="1192.2" y1="1218.4" x2="1189.6" y2="1224.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21 Gambia: 33 samples</title>
	<line x1="1189.6" y1="1224.6" x2="1186.9" y2="1230.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21 Uganda: 3 samples</title>
	<line x1="1186.9" y1="1230.9" x2="1185.8" y2="1233.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-21  G22706T  Gambia=20 [60.6%]  surface glycoprotein, V382L</title>
	<circle cx="1032.0" cy="1595.9" r="5.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  Gambia=33 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="6.1" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  Gambia=33 [100.0%] South Africa=30 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="5.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  A23403G  Gambia=33 [100.0%] South Africa=30 [100.0%] Uganda=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="971.3" cy="1738.8" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  C25292T  South Africa=3 [10.0%]  surface glycoprotein, L1244F</title>
	<circle cx="806.9" cy="2126.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-21  G25455T  South Africa=2 [6.7%]  ORF3a protein, K21N</title>
	<circle cx="792.7" cy="2159.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22 South Africa: 44 samples</title>
	<line x1="1191.9" y1="1218.3" x2="1188.8" y2="1225.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-22 Gambia: 9 samples</title>
	<line x1="1188.8" y1="1225.1" x2="1187.0" y2="1229.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-22  G22706T  Gambia=4 [44.4%]  surface glycoprotein, V382L</title>
	<circle cx="1025.1" cy="1592.9" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A23403G  South Africa=44 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="961.9" cy="1734.7" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A23403G  South Africa=44 [100.0%] Gambia=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="961.9" cy="1734.7" r="3.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  A23534G  South Africa=2 [4.5%]  surface glycoprotein, N658D</title>
	<circle cx="950.1" cy="1761.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  G23868T  South Africa=2 [4.5%]  surface glycoprotein, G769V</title>
	<circle cx="919.8" cy="1829.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-22  G25455T  South Africa=9 [20.5%]  ORF3a protein, K21N</title>
	<circle cx="776.1" cy="2152.2" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-23 South Africa: 19 samples</title>
	<line x1="1191.5" y1="1218.1" x2="1189.1" y2="1223.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-23  A23403G  South Africa=19 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="952.6" cy="1730.5" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24 South Africa: 7 samples</title>
	<line x1="1191.2" y1="1218.0" x2="1189.5" y2="1221.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24 Gambia: 10 samples</title>
	<line x1="1189.5" y1="1221.6" x2="1187.4" y2="1225.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24 Uganda: 2 samples</title>
	<line x1="1187.4" y1="1225.8" x2="1186.5" y2="1227.8" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-24  A23403G  Gambia=10 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="1726.1" r="4.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  A23403G  Gambia=10 [100.0%] South Africa=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="943.4" cy="1726.1" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-24  C23625T  South Africa=3 [42.9%]  surface glycoprotein, A688V</title>
	<circle cx="921.7" cy="1770.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-25 Gambia: 12 samples</title>
	<line x1="1190.9" y1="1217.8" x2="1188.6" y2="1222.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-25  A23403G  Gambia=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="934.3" cy="1721.5" r="4.3" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27 South Africa: 14 samples</title>
	<line x1="1190.3" y1="1217.5" x2="1187.7" y2="1222.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-27 Gambia: 87 samples</title>
	<line x1="1187.7" y1="1222.1" x2="1183.5" y2="1229.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-27  G22706T  Gambia=23 [26.4%]  surface glycoprotein, V382L</title>
	<circle cx="991.5" cy="1576.1" r="5.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A23403G  Gambia=87 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="1711.9" r="7.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  A23403G  Gambia=87 [100.0%] South Africa=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="1711.9" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C23625T  South Africa=2 [14.3%]  surface glycoprotein, A688V</title>
	<circle cx="892.3" cy="1755.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G24368T  Gambia=5 [5.7%]  surface glycoprotein, D936Y</title>
	<circle cx="812.0" cy="1899.9" r="2.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  C24374T  Gambia=3 [3.4%]  surface glycoprotein, L938F</title>
	<circle cx="811.4" cy="1901.1" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-27  G24620T  Gambia=11 [12.6%]  surface glycoprotein, A1020S</title>
	<circle cx="784.8" cy="1949.0" r="4.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28 South Africa: 8 samples</title>
	<line x1="1190.0" y1="1217.3" x2="1187.9" y2="1221.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-28 Gambia: 2 samples</title>
	<line x1="1187.9" y1="1221.0" x2="1186.8" y2="1222.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-28  G22706T  Gambia=2 [100.0%]  surface glycoprotein, V382L</title>
	<circle cx="985.0" cy="1572.4" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="1706.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-28  A23403G  South Africa=8 [100.0%] Gambia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="1706.9" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29 South Africa: 26 samples</title>
	<line x1="1189.7" y1="1217.1" x2="1186.4" y2="1222.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-29  A23403G  South Africa=26 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="1701.7" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  C23625T  South Africa=4 [15.4%]  surface glycoprotein, A688V</title>
	<circle cx="873.1" cy="1744.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-29  G25455T  South Africa=2 [7.7%]  ORF3a protein, K21N</title>
	<circle cx="663.2" cy="2093.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30 South Africa: 57 samples</title>
	<line x1="1189.4" y1="1217.0" x2="1185.2" y2="1223.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-30 Gambia: 12 samples</title>
	<line x1="1185.2" y1="1223.7" x2="1182.5" y2="1227.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-30  G22706T  Gambia=2 [16.7%]  surface glycoprotein, V382L</title>
	<circle cx="972.1" cy="1564.7" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  A23403G  South Africa=57 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="889.8" cy="1696.4" r="7.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  A23403G  South Africa=57 [100.0%] Gambia=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="889.8" cy="1696.4" r="4.3" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  C23625T  South Africa=2 [3.5%]  surface glycoprotein, A688V</title>
	<circle cx="863.6" cy="1738.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-30  G25455T  South Africa=3 [5.3%]  ORF3a protein, K21N</title>
	<circle cx="647.7" cy="2083.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-07-31 South Africa: 20 samples</title>
	<line x1="1189.1" y1="1216.8" x2="1185.9" y2="1221.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-07-31  A23403G  South Africa=20 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="881.2" cy="1690.9" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-01 South Africa: 17 samples</title>
	<line x1="1188.8" y1="1216.6" x2="1185.7" y2="1221.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-01  A23403G  South Africa=17 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="872.7" cy="1685.2" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-02 South Africa: 13 samples</title>
	<line x1="1188.5" y1="1216.4" x2="1185.6" y2="1220.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-02  A23403G  South Africa=12 [92.3%]  surface glycoprotein, D614G</title>
	<circle cx="864.3" cy="1679.5" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-03 South Africa: 16 samples</title>
	<line x1="1188.2" y1="1216.2" x2="1185.0" y2="1220.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-03  A23403G  South Africa=16 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="1673.5" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04 South Africa: 5 samples</title>
	<line x1="1188.0" y1="1216.0" x2="1185.9" y2="1218.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-04 SaudiArabia: 7 samples</title>
	<line x1="1185.9" y1="1218.8" x2="1183.4" y2="1222.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-04 Gambia: 4 samples</title>
	<line x1="1183.4" y1="1222.0" x2="1181.5" y2="1224.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-04  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="1667.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  A23403G  SaudiArabia=5 [71.4%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="1667.4" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-04  A23403G  SaudiArabia=5 [71.4%] Gambia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="1667.4" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-05 South Africa: 4 samples</title>
	<line x1="1187.7" y1="1215.8" x2="1185.8" y2="1218.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-05  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="1661.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-06 South Africa: 5 samples</title>
	<line x1="1187.4" y1="1215.5" x2="1185.2" y2="1218.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-06  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="1654.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-07 South Africa: 8 samples</title>
	<line x1="1187.1" y1="1215.3" x2="1184.4" y2="1218.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-07  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="823.8" cy="1648.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08 Uganda: 3 samples</title>
	<line x1="1186.9" y1="1215.1" x2="1185.1" y2="1217.1" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-08  G21624A  Uganda=2 [66.7%]  surface glycoprotein, R21K</title>
	<circle cx="1075.9" cy="1342.7" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-08  A23403G  Uganda=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="1641.7" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-11 South Africa: 12 samples</title>
	<line x1="1186.1" y1="1214.4" x2="1182.6" y2="1218.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-11  A23403G  South Africa=11 [91.7%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="1621.0" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-12 South Africa: 9 samples</title>
	<line x1="1185.9" y1="1214.1" x2="1182.7" y2="1217.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-12 Burkina Faso: 2 samples</title>
	<line x1="1182.7" y1="1217.3" x2="1181.2" y2="1218.8" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-12  A23403G  South Africa=8 [88.9%]  surface glycoprotein, D614G</title>
	<circle cx="786.1" cy="1613.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13 South Africa: 5 samples</title>
	<line x1="1185.6" y1="1213.9" x2="1183.1" y2="1216.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-13 Gambia: 4 samples</title>
	<line x1="1183.1" y1="1216.3" x2="1180.8" y2="1218.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-13 Burkina Faso: 2 samples</title>
	<line x1="1180.8" y1="1218.5" x2="1179.3" y2="1220.0" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-13  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="1606.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A23403G  South Africa=5 [100.0%] Gambia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="1606.6" r="2.4" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-13  A23403G  South Africa=5 [100.0%] Gambia=4 [100.0%] Burkina Faso=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="1606.6" r="1.2" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14 South Africa: 11 samples</title>
	<line x1="1185.4" y1="1213.6" x2="1181.8" y2="1217.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14 Uganda: 2 samples</title>
	<line x1="1181.8" y1="1217.0" x2="1180.3" y2="1218.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14 Egypt: 11 samples</title>
	<line x1="1180.3" y1="1218.4" x2="1176.7" y2="1221.7" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14 Burkina Faso: 4 samples</title>
	<line x1="1176.7" y1="1221.7" x2="1174.4" y2="1223.9" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-14  A23403G  Egypt=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="1599.2" r="4.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  A23403G  Egypt=11 [100.0%] South Africa=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="1599.2" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-14  A23403G  Egypt=11 [100.0%] South Africa=11 [100.0%] Burkina Faso=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="1599.2" r="2.4" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15 South Africa: 12 samples</title>
	<line x1="1185.1" y1="1213.4" x2="1181.4" y2="1216.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-15 Uganda: 11 samples</title>
	<line x1="1181.4" y1="1216.7" x2="1177.8" y2="1220.0" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-15  C22033A  Uganda=10 [90.9%]  surface glycoprotein, F157L</title>
	<circle cx="991.8" cy="1387.5" r="4.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  G22661T  Uganda=10 [90.9%]  surface glycoprotein, V367F</title>
	<circle cx="887.8" cy="1481.1" r="4.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  G23401T  Uganda=10 [90.9%]  surface glycoprotein, Q613H</title>
	<circle cx="765.4" cy="1591.3" r="4.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-15  A23403G  South Africa=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="765.0" cy="1591.6" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-16 South Africa: 9 samples</title>
	<line x1="1184.9" y1="1213.1" x2="1181.5" y2="1216.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-16  A23403G  South Africa=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="1584.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17 South Africa: 2 samples</title>
	<line x1="1184.7" y1="1212.9" x2="1183.0" y2="1214.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17 Gambia: 2 samples</title>
	<line x1="1183.0" y1="1214.2" x2="1181.4" y2="1215.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17 Uganda: 3 samples</title>
	<line x1="1181.4" y1="1215.6" x2="1179.3" y2="1217.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17 Egypt: 11 samples</title>
	<line x1="1179.3" y1="1217.4" x2="1175.6" y2="1220.5" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-17  A23403G  Egypt=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="1576.2" r="4.2" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A23403G  Egypt=11 [100.0%] Uganda=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="1576.2" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A23403G  Egypt=11 [100.0%] Uganda=3 [100.0%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="1576.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-17  A23403G  Egypt=11 [100.0%] Uganda=3 [100.0%] South Africa=2 [100.0%] Gambia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="1576.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18 South Africa: 4 samples</title>
	<line x1="1184.5" y1="1212.6" x2="1182.0" y2="1214.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-18 Gambia: 3 samples</title>
	<line x1="1182.0" y1="1214.6" x2="1179.9" y2="1216.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-18  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="745.1" cy="1568.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-18  A23403G  South Africa=4 [100.0%] Gambia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="745.1" cy="1568.3" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-19 South Africa: 3 samples</title>
	<line x1="1184.2" y1="1212.3" x2="1182.1" y2="1214.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-19  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="1560.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20 South Africa: 8 samples</title>
	<line x1="1184.0" y1="1212.0" x2="1180.6" y2="1214.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-20 Gambia: 3 samples</title>
	<line x1="1180.6" y1="1214.6" x2="1178.4" y2="1216.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-20  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="1552.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-20  A23403G  South Africa=8 [100.0%] Gambia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="1552.2" r="1.9" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21 South Africa: 14 samples</title>
	<line x1="1183.8" y1="1211.8" x2="1179.5" y2="1214.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-21 Uganda: 2 samples</title>
	<line x1="1179.5" y1="1214.9" x2="1177.8" y2="1216.1" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-21  A23403G  South Africa=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="1544.0" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  C23664T  South Africa=2 [14.3%]  surface glycoprotein, A701V</title>
	<circle cx="679.5" cy="1578.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-21  G25455T  South Africa=2 [14.3%]  ORF3a protein, K21N</title>
	<circle cx="356.7" cy="1812.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-22 Egypt: 12 samples</title>
	<line x1="1183.6" y1="1211.5" x2="1179.5" y2="1214.3" style="stroke:#FFBBFF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-22  A23403G  Egypt=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="1535.7" r="4.3" style="fill:#FFBBFF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23 South Africa: 5 samples</title>
	<line x1="1183.4" y1="1211.2" x2="1180.5" y2="1213.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-23  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="1527.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-23  G25455T  South Africa=3 [60.0%]  ORF3a protein, K21N</title>
	<circle cx="335.9" cy="1782.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24 South Africa: 16 samples</title>
	<line x1="1183.2" y1="1210.9" x2="1178.6" y2="1213.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-24 Uganda: 5 samples</title>
	<line x1="1178.6" y1="1213.9" x2="1175.6" y2="1215.8" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-24  A23403G  South Africa=16 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="1518.8" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-24  A23403G  Uganda=3 [60.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="1518.8" r="1.9" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25 South Africa: 6 samples</title>
	<line x1="1183.0" y1="1210.6" x2="1179.8" y2="1212.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25 Gambia: 2 samples</title>
	<line x1="1179.8" y1="1212.6" x2="1178.0" y2="1213.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25 Uganda: 2 samples</title>
	<line x1="1178.0" y1="1213.8" x2="1176.2" y2="1214.9" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-25  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="1510.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-25  A23403G  South Africa=6 [100.0%] Gambia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="1510.2" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26 South Africa: 2 samples</title>
	<line x1="1182.9" y1="1210.3" x2="1181.0" y2="1211.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-26 Uganda: 9 samples</title>
	<line x1="1181.0" y1="1211.4" x2="1177.2" y2="1213.7" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-26  G23236T  Uganda=2 [22.2%]  surface glycoprotein, K558N</title>
	<circle cx="730.2" cy="1482.3" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A23403G  Uganda=6 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="1501.5" r="3.1" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-26  A23403G  Uganda=6 [66.7%] South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="1501.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-27 Uganda: 3 samples</title>
	<line x1="1182.7" y1="1210.0" x2="1180.3" y2="1211.4" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-27  A23403G  Uganda=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="1492.7" r="1.2" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-28 South Africa: 3 samples</title>
	<line x1="1182.5" y1="1209.7" x2="1180.1" y2="1211.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-28  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="688.1" cy="1483.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-29 South Africa: 6 samples</title>
	<line x1="1182.3" y1="1209.4" x2="1179.0" y2="1211.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-29  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="1474.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30 South Africa: 2 samples</title>
	<line x1="1182.2" y1="1209.1" x2="1180.3" y2="1210.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-30 Rwanda: 2 samples</title>
	<line x1="1180.3" y1="1210.1" x2="1178.4" y2="1211.0" style="stroke:#bc80bd;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-30  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="678.5" cy="1465.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-30  A23403G  South Africa=2 [100.0%] Rwanda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="678.5" cy="1465.7" r="1.2" style="fill:#bc80bd;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31 South Africa: 17 samples</title>
	<line x1="1182.0" y1="1208.8" x2="1176.9" y2="1211.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-08-31  C21846T  South Africa=2 [11.8%]  surface glycoprotein, T95I</title>
	<circle cx="985.6" cy="1304.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  A23403G  South Africa=17 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="1456.6" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  C23625T  South Africa=2 [11.8%]  surface glycoprotein, A688V</title>
	<circle cx="629.5" cy="1478.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-08-31  G23868T  South Africa=2 [11.8%]  surface glycoprotein, G769V</title>
	<circle cx="580.9" cy="1502.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01 South Africa: 17 samples</title>
	<line x1="1181.9" y1="1208.5" x2="1176.8" y2="1210.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-01 Uganda: 12 samples</title>
	<line x1="1176.8" y1="1210.8" x2="1172.2" y2="1213.0" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-01  C22033A  Uganda=12 [100.0%]  surface glycoprotein, F157L</title>
	<circle cx="946.1" cy="1318.4" r="4.3" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G22661T  Uganda=12 [100.0%]  surface glycoprotein, V367F</title>
	<circle cx="819.3" cy="1377.5" r="4.3" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  G23401T  Uganda=12 [100.0%]  surface glycoprotein, Q613H</title>
	<circle cx="669.9" cy="1447.2" r="4.3" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-01  A23403G  South Africa=17 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="1447.4" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-02 South Africa: 6 samples</title>
	<line x1="1181.7" y1="1208.1" x2="1178.3" y2="1209.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-02  A23403G  South Africa=5 [83.3%]  surface glycoprotein, D614G</title>
	<circle cx="665.3" cy="1438.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-03 South Africa: 6 samples</title>
	<line x1="1181.6" y1="1207.8" x2="1178.1" y2="1209.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-03  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="1428.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04 South Africa: 36 samples</title>
	<line x1="1181.5" y1="1207.5" x2="1174.9" y2="1210.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-04  G21604T  South Africa=2 [5.6%]  surface glycoprotein, Q14H</title>
	<circle cx="1028.8" cy="1269.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  A23403G  South Africa=36 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="657.3" cy="1419.3" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-04  G25088T  South Africa=3 [8.3%]  surface glycoprotein, V1176F</title>
	<circle cx="309.4" cy="1559.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-05 South Africa: 12 samples</title>
	<line x1="1181.3" y1="1207.2" x2="1176.6" y2="1209.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-05  A23403G  South Africa=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="653.6" cy="1409.8" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-06 South Africa: 4 samples</title>
	<line x1="1181.2" y1="1206.8" x2="1178.3" y2="1207.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-06  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="650.0" cy="1400.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07 South Africa: 18 samples</title>
	<line x1="1181.1" y1="1206.5" x2="1175.6" y2="1208.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-07  A23403G  South Africa=18 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="646.6" cy="1390.6" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-07  G25455T  South Africa=2 [11.1%]  ORF3a protein, K21N</title>
	<circle cx="214.5" cy="1539.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09 South Africa: 5 samples</title>
	<line x1="1180.9" y1="1205.8" x2="1177.5" y2="1206.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-09 Burkina Faso: 2 samples</title>
	<line x1="1177.5" y1="1206.9" x2="1175.5" y2="1207.5" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-09  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="640.3" cy="1371.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-09  A23403G  South Africa=5 [100.0%] Burkina Faso=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="640.3" cy="1371.1" r="1.2" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10 South Africa: 17 samples</title>
	<line x1="1180.8" y1="1205.5" x2="1175.3" y2="1207.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-10  A23403G  South Africa=17 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="637.4" cy="1361.3" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-10  C23997T  South Africa=2 [11.8%]  surface glycoprotein, P812L</title>
	<circle cx="510.2" cy="1397.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11 South Africa: 12 samples</title>
	<line x1="1180.7" y1="1205.2" x2="1175.8" y2="1206.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-11 Tunisia: 2 samples</title>
	<line x1="1175.8" y1="1206.5" x2="1173.8" y2="1207.0" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-11 Burkina Faso: 8 samples</title>
	<line x1="1173.8" y1="1207.0" x2="1169.6" y2="1208.1" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-11  A23403G  South Africa=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1351.5" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  A23403G  South Africa=12 [100.0%] Burkina Faso=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1351.5" r="3.6" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-11  A23403G  South Africa=12 [100.0%] Burkina Faso=8 [100.0%] Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1351.5" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-12 South Africa: 4 samples</title>
	<line x1="1180.6" y1="1204.8" x2="1177.5" y2="1205.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-12  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1341.6" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13 South Africa: 9 samples</title>
	<line x1="1180.5" y1="1204.5" x2="1176.1" y2="1205.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-13 Tunisia: 4 samples</title>
	<line x1="1176.1" y1="1205.5" x2="1173.1" y2="1206.2" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-13  A23403G  South Africa=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1331.7" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-13  A23403G  South Africa=9 [100.0%] Tunisia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1331.7" r="2.4" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14 South Africa: 10 samples</title>
	<line x1="1180.4" y1="1204.2" x2="1175.9" y2="1205.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-14 Tunisia: 2 samples</title>
	<line x1="1175.9" y1="1205.1" x2="1173.8" y2="1205.6" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-14  A23403G  South Africa=9 [90.0%]  surface glycoprotein, D614G</title>
	<circle cx="627.5" cy="1321.7" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-14  A23403G  South Africa=9 [90.0%] Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="627.5" cy="1321.7" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15 Tunisia: 7 samples</title>
	<line x1="1180.4" y1="1203.8" x2="1176.4" y2="1204.6" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-15  C22227T  Tunisia=4 [57.1%]  surface glycoprotein, A222V</title>
	<circle cx="882.6" cy="1261.7" r="2.4" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-15  A23403G  Tunisia=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="625.5" cy="1311.7" r="3.4" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16 South Africa: 5 samples</title>
	<line x1="1180.3" y1="1203.5" x2="1176.9" y2="1204.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-16 Burkina Faso: 3 samples</title>
	<line x1="1176.9" y1="1204.1" x2="1174.2" y2="1204.6" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-16  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="623.6" cy="1301.6" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-16  A23403G  Burkina Faso=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="623.6" cy="1301.6" r="1.2" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-17 Burkina Faso: 2 samples</title>
	<line x1="1180.2" y1="1203.1" x2="1178.1" y2="1203.5" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-17  A23403G  Burkina Faso=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="621.9" cy="1291.6" r="1.2" style="fill:#7FFFD4;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-18 South Africa: 6 samples</title>
	<line x1="1180.2" y1="1202.8" x2="1176.4" y2="1203.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-18  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="620.4" cy="1281.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22 South Africa: 2 samples</title>
	<line x1="1180.0" y1="1201.4" x2="1177.9" y2="1201.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-22 Gambia: 2 samples</title>
	<line x1="1177.9" y1="1201.5" x2="1175.8" y2="1201.7" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-22  G23285T  South Africa=2 [100.0%]  surface glycoprotein, A575S</title>
	<circle cx="642.3" cy="1239.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.1" cy="1240.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-22  A23403G  South Africa=2 [100.0%] Gambia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.1" cy="1240.8" r="1.2" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23 South Africa: 9 samples</title>
	<line x1="1180.0" y1="1201.0" x2="1175.5" y2="1201.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-23  A23403G  South Africa=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.5" cy="1230.6" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-23  C24809T  South Africa=2 [22.2%]  surface glycoprotein, H1083Y</title>
	<circle cx="302.8" cy="1247.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-24 South Africa: 3 samples</title>
	<line x1="1180.0" y1="1200.7" x2="1177.3" y2="1200.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-24  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.1" cy="1220.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-25 South Africa: 16 samples</title>
	<line x1="1180.0" y1="1200.3" x2="1174.5" y2="1200.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-25  A23403G  South Africa=16 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="614.8" cy="1210.2" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-26 South Africa: 11 samples</title>
	<line x1="1180.0" y1="1200.0" x2="1175.1" y2="1200.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-26  A23403G  South Africa=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="614.7" cy="1200.0" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-27 South Africa: 2 samples</title>
	<line x1="1180.0" y1="1199.7" x2="1177.9" y2="1199.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-27  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="614.8" cy="1189.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28 South Africa: 15 samples</title>
	<line x1="1180.0" y1="1199.3" x2="1174.6" y2="1199.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-28  A23403G  South Africa=15 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.1" cy="1179.6" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-28  G23587C  South Africa=2 [13.3%]  surface glycoprotein, Q675H</title>
	<circle cx="574.1" cy="1178.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-29 South Africa: 5 samples</title>
	<line x1="1180.0" y1="1199.0" x2="1176.5" y2="1198.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-29  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="615.5" cy="1169.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30 South Africa: 8 samples</title>
	<line x1="1180.0" y1="1198.6" x2="1175.8" y2="1198.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-09-30  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.1" cy="1159.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-09-30  C23625T  South Africa=2 [25.0%]  surface glycoprotein, A688V</title>
	<circle cx="566.8" cy="1155.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01 South Africa: 4 samples</title>
	<line x1="1180.1" y1="1198.3" x2="1176.9" y2="1198.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-01 Uganda: 6 samples</title>
	<line x1="1176.9" y1="1198.0" x2="1173.2" y2="1197.7" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-01  A23403G  Uganda=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.9" cy="1149.0" r="3.1" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  A23403G  Uganda=6 [100.0%] South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="616.9" cy="1149.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  C24863T  Uganda=6 [100.0%]  surface glycoprotein, H1101Y</title>
	<circle cx="293.0" cy="1120.6" r="3.1" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-01  G25429T  Uganda=6 [100.0%]  ORF3a protein, V13L</title>
	<circle cx="167.4" cy="1109.7" r="3.1" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-03 South Africa: 4 samples</title>
	<line x1="1180.1" y1="1197.6" x2="1177.0" y2="1197.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-03  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="619.1" cy="1128.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-04 South Africa: 4 samples</title>
	<line x1="1180.2" y1="1197.2" x2="1177.1" y2="1196.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-04  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="620.4" cy="1118.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-05 South Africa: 8 samples</title>
	<line x1="1180.2" y1="1196.9" x2="1176.0" y2="1196.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-05  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="621.9" cy="1108.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-06 South Africa: 12 samples</title>
	<line x1="1180.3" y1="1196.5" x2="1175.4" y2="1195.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-06  A23403G  South Africa=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="623.6" cy="1098.4" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-07 South Africa: 6 samples</title>
	<line x1="1180.4" y1="1196.2" x2="1176.6" y2="1195.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-07  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="625.5" cy="1088.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-08 South Africa: 4 samples</title>
	<line x1="1180.4" y1="1195.8" x2="1177.4" y2="1195.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-08  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="627.5" cy="1078.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09 South Africa: 16 samples</title>
	<line x1="1180.5" y1="1195.5" x2="1175.1" y2="1194.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-09 Burkina Faso: 2 samples</title>
	<line x1="1175.1" y1="1194.3" x2="1173.0" y2="1193.8" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-09  A23403G  South Africa=16 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="629.7" cy="1068.3" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G23587C  South Africa=2 [12.5%]  surface glycoprotein, Q675H</title>
	<circle cx="589.8" cy="1059.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-09  G25455T  South Africa=2 [12.5%]  ORF3a protein, K21N</title>
	<circle cx="184.4" cy="965.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-10 South Africa: 5 samples</title>
	<line x1="1180.6" y1="1195.2" x2="1177.2" y2="1194.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-10  A23403G  South Africa=4 [80.0%]  surface glycoprotein, D614G</title>
	<circle cx="632.1" cy="1058.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-11 South Africa: 2 samples</title>
	<line x1="1180.7" y1="1194.8" x2="1178.6" y2="1194.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-11  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="634.6" cy="1048.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12 South Africa: 11 samples</title>
	<line x1="1180.8" y1="1194.5" x2="1176.1" y2="1193.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-12  A23403G  South Africa=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="637.4" cy="1038.7" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-12  G23628T  South Africa=3 [27.3%]  surface glycoprotein, S689I</title>
	<circle cx="589.2" cy="1024.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-13 South Africa: 2 samples</title>
	<line x1="1180.9" y1="1194.2" x2="1178.8" y2="1193.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-13  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="640.3" cy="1028.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14 South Africa: 8 samples</title>
	<line x1="1181.0" y1="1193.8" x2="1176.9" y2="1192.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-14 Tunisia: 2 samples</title>
	<line x1="1176.9" y1="1192.5" x2="1174.9" y2="1191.8" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-14  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="643.3" cy="1019.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-14  A23403G  South Africa=8 [100.0%] Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="643.3" cy="1019.1" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15 South Africa: 13 samples</title>
	<line x1="1181.1" y1="1193.5" x2="1176.2" y2="1191.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-15  A21801C  South Africa=3 [23.1%]  surface glycoprotein, D80A</title>
	<circle cx="983.9" cy="1125.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G22299T  South Africa=2 [15.4%]  surface glycoprotein, R246I</title>
	<circle cx="879.1" cy="1089.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G22813T  South Africa=3 [23.1%]  surface glycoprotein, K417N</title>
	<circle cx="770.8" cy="1052.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  G23012A  South Africa=3 [23.1%]  surface glycoprotein, E484K</title>
	<circle cx="728.9" cy="1037.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  A23063T  South Africa=3 [23.1%]  surface glycoprotein, N501Y</title>
	<circle cx="718.2" cy="1034.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  A23403G  South Africa=13 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="646.6" cy="1009.4" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-15  C23664T  South Africa=4 [30.8%]  surface glycoprotein, A701V</title>
	<circle cx="591.6" cy="990.5" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16 South Africa: 5 samples</title>
	<line x1="1181.2" y1="1193.2" x2="1177.9" y2="1192.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-16 Tunisia: 2 samples</title>
	<line x1="1177.9" y1="1192.0" x2="1175.9" y2="1191.2" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-16  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="650.0" cy="999.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-16  A23403G  South Africa=5 [100.0%] Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="650.0" cy="999.8" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-17 South Africa: 2 samples</title>
	<line x1="1181.3" y1="1192.8" x2="1179.3" y2="1192.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-17  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="653.6" cy="990.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18 South Africa: 14 samples</title>
	<line x1="1181.5" y1="1192.5" x2="1176.5" y2="1190.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-18  A23403G  South Africa=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="657.3" cy="980.7" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-18  C24378T  South Africa=5 [35.7%]  surface glycoprotein, S939F</title>
	<circle cx="456.0" cy="899.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19 South Africa: 19 samples</title>
	<line x1="1181.6" y1="1192.2" x2="1176.2" y2="1189.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-19 Tunisia: 2 samples</title>
	<line x1="1176.2" y1="1189.9" x2="1174.2" y2="1189.1" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-19 Rwanda: 2 samples</title>
	<line x1="1174.2" y1="1189.1" x2="1172.2" y2="1188.2" style="stroke:#bc80bd;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-19  A21801C  South Africa=2 [10.5%]  surface glycoprotein, D80A</title>
	<circle cx="989.7" cy="1110.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G22021A  South Africa=2 [10.5%]  surface glycoprotein, M153I</title>
	<circle cx="944.6" cy="1091.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G22299T  South Africa=2 [10.5%]  surface glycoprotein, R246I</title>
	<circle cx="887.6" cy="1067.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G22813T  South Africa=2 [10.5%]  surface glycoprotein, K417N</title>
	<circle cx="782.2" cy="1022.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G23012A  South Africa=2 [10.5%]  surface glycoprotein, E484K</title>
	<circle cx="741.4" cy="1005.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A23063T  South Africa=2 [10.5%]  surface glycoprotein, N501Y</title>
	<circle cx="730.9" cy="1000.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A23403G  South Africa=19 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="971.3" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A23403G  South Africa=19 [100.0%] Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="971.3" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  A23403G  South Africa=19 [100.0%] Tunisia=2 [100.0%] Rwanda=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="661.2" cy="971.3" r="1.2" style="fill:#bc80bd;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  C23664T  South Africa=3 [15.8%]  surface glycoprotein, A701V</title>
	<circle cx="607.7" cy="948.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-19  G25455T  South Africa=2 [10.5%]  ORF3a protein, K21N</title>
	<circle cx="240.5" cy="792.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20 South Africa: 17 samples</title>
	<line x1="1181.7" y1="1191.9" x2="1176.6" y2="1189.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-20  A23403G  South Africa=17 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="665.3" cy="961.9" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-20  C24381T  South Africa=2 [11.8%]  surface glycoprotein, S940F</title>
	<circle cx="466.3" cy="873.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-21 South Africa: 3 samples</title>
	<line x1="1181.9" y1="1191.5" x2="1179.4" y2="1190.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-21  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="669.5" cy="952.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22 South Africa: 12 samples</title>
	<line x1="1182.0" y1="1191.2" x2="1177.5" y2="1189.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-22  A21801C  South Africa=3 [25.0%]  surface glycoprotein, D80A</title>
	<circle cx="994.6" cy="1099.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C22214G  South Africa=2 [16.7%]  surface glycoprotein, Q218E</title>
	<circle cx="911.9" cy="1059.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G22813T  South Africa=3 [25.0%]  surface glycoprotein, K417N</title>
	<circle cx="792.0" cy="1001.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  G23012A  South Africa=3 [25.0%]  surface glycoprotein, E484K</title>
	<circle cx="752.2" cy="981.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  A23063T  South Africa=3 [25.0%]  surface glycoprotein, N501Y</title>
	<circle cx="742.0" cy="976.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  A23403G  South Africa=12 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="673.9" cy="943.4" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-22  C23664T  South Africa=3 [25.0%]  surface glycoprotein, A701V</title>
	<circle cx="621.7" cy="917.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23 South Africa: 6 samples</title>
	<line x1="1182.2" y1="1190.9" x2="1178.8" y2="1189.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-23  A21801C  South Africa=5 [83.3%]  surface glycoprotein, D80A</title>
	<circle cx="996.4" cy="1096.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G22299T  South Africa=4 [66.7%]  surface glycoprotein, R246I</title>
	<circle cx="897.6" cy="1045.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G22813T  South Africa=5 [83.3%]  surface glycoprotein, K417N</title>
	<circle cx="795.6" cy="993.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  G23012A  South Africa=5 [83.3%]  surface glycoprotein, E484K</title>
	<circle cx="756.1" cy="973.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  A23063T  South Africa=5 [83.3%]  surface glycoprotein, N501Y</title>
	<circle cx="746.0" cy="968.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="678.5" cy="934.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-23  C23664T  South Africa=5 [83.3%]  surface glycoprotein, A701V</title>
	<circle cx="626.7" cy="907.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-24 South Africa: 6 samples</title>
	<line x1="1182.3" y1="1190.6" x2="1179.0" y2="1188.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-24  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="683.2" cy="925.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-25 South Africa: 5 samples</title>
	<line x1="1182.5" y1="1190.3" x2="1179.4" y2="1188.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-25  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="688.1" cy="916.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26 South Africa: 13 samples</title>
	<line x1="1182.7" y1="1190.0" x2="1178.2" y2="1187.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-26 Cameroon: 2 samples</title>
	<line x1="1178.2" y1="1187.4" x2="1176.4" y2="1186.3" style="stroke:#CC00FF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-26  A21801C  South Africa=2 [15.4%]  surface glycoprotein, D80A</title>
	<circle cx="1002.1" cy="1085.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  C22227T  Cameroon=2 [100.0%]  surface glycoprotein, A222V</title>
	<circle cx="919.9" cy="1038.3" r="1.2" style="fill:#CC00FF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G22813T  South Africa=2 [15.4%]  surface glycoprotein, K417N</title>
	<circle cx="806.9" cy="973.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  G23012A  South Africa=2 [15.4%]  surface glycoprotein, E484K</title>
	<circle cx="768.5" cy="950.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A23063T  South Africa=2 [15.4%]  surface glycoprotein, N501Y</title>
	<circle cx="758.7" cy="945.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A23403G  South Africa=13 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="907.3" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  A23403G  South Africa=13 [100.0%] Cameroon=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="693.1" cy="907.3" r="1.2" style="fill:#CC00FF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  C23664T  South Africa=2 [15.4%]  surface glycoprotein, A701V</title>
	<circle cx="642.8" cy="878.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-26  C24378T  South Africa=3 [23.1%]  surface glycoprotein, S939F</title>
	<circle cx="505.1" cy="798.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27 South Africa: 17 samples</title>
	<line x1="1182.9" y1="1189.7" x2="1178.0" y2="1186.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-27 Burkina Faso: 2 samples</title>
	<line x1="1178.0" y1="1186.8" x2="1176.2" y2="1185.7" style="stroke:#7FFFD4;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-27  A21801C  South Africa=2 [11.8%]  surface glycoprotein, D80A</title>
	<circle cx="1004.1" cy="1082.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C22214G  South Africa=2 [11.8%]  surface glycoprotein, Q218E</title>
	<circle cx="925.3" cy="1034.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G22299T  South Africa=2 [11.8%]  surface glycoprotein, R246I</title>
	<circle cx="909.1" cy="1025.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G22813T  South Africa=2 [11.8%]  surface glycoprotein, K417N</title>
	<circle cx="810.9" cy="966.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  G23012A  South Africa=2 [11.8%]  surface glycoprotein, E484K</title>
	<circle cx="772.9" cy="943.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  A23063T  South Africa=2 [11.8%]  surface glycoprotein, N501Y</title>
	<circle cx="763.2" cy="937.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  A23403G  South Africa=17 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="698.3" cy="898.5" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-27  C23664T  South Africa=2 [11.8%]  surface glycoprotein, A701V</title>
	<circle cx="648.5" cy="868.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28 South Africa: 6 samples</title>
	<line x1="1183.0" y1="1189.4" x2="1179.8" y2="1187.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-28  A21801C  South Africa=3 [50.0%]  surface glycoprotein, D80A</title>
	<circle cx="1006.2" cy="1078.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G22299T  South Africa=2 [33.3%]  surface glycoprotein, R246I</title>
	<circle cx="912.2" cy="1020.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G22813T  South Africa=3 [50.0%]  surface glycoprotein, K417N</title>
	<circle cx="815.1" cy="959.5" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  G23012A  South Africa=3 [50.0%]  surface glycoprotein, E484K</title>
	<circle cx="777.5" cy="936.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  T23031C  South Africa=2 [33.3%]  surface glycoprotein, F490S</title>
	<circle cx="773.9" cy="933.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  A23063T  South Africa=3 [50.0%]  surface glycoprotein, N501Y</title>
	<circle cx="767.9" cy="930.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="703.6" cy="889.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-28  C23664T  South Africa=3 [50.0%]  surface glycoprotein, A701V</title>
	<circle cx="654.3" cy="859.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29 South Africa: 6 samples</title>
	<line x1="1183.2" y1="1189.1" x2="1180.0" y2="1187.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-29  A21801C  South Africa=2 [33.3%]  surface glycoprotein, D80A</title>
	<circle cx="1008.4" cy="1075.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G22813T  South Africa=2 [33.3%]  surface glycoprotein, K417N</title>
	<circle cx="819.3" cy="952.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  G23012A  South Africa=2 [33.3%]  surface glycoprotein, E484K</title>
	<circle cx="782.2" cy="928.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  A23063T  South Africa=2 [33.3%]  surface glycoprotein, N501Y</title>
	<circle cx="772.6" cy="922.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="709.1" cy="881.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-29  C23664T  South Africa=2 [33.3%]  surface glycoprotein, A701V</title>
	<circle cx="660.4" cy="849.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-30 South Africa: 7 samples</title>
	<line x1="1183.4" y1="1188.8" x2="1180.1" y2="1186.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-30  A23403G  South Africa=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="714.8" cy="872.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-10-31 Tunisia: 2 samples</title>
	<line x1="1183.6" y1="1188.5" x2="1181.9" y2="1187.3" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-10-31  A23403G  Tunisia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="720.5" cy="864.3" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-01 South Africa: 3 samples</title>
	<line x1="1183.8" y1="1188.2" x2="1181.6" y2="1186.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-01  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="726.5" cy="856.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02 South Africa: 14 samples</title>
	<line x1="1184.0" y1="1188.0" x2="1179.8" y2="1184.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-02 Tunisia: 4 samples</title>
	<line x1="1179.8" y1="1184.8" x2="1177.3" y2="1182.9" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-02  C21575T  Tunisia=2 [50.0%]  surface glycoprotein, L5F</title>
	<circle cx="1057.7" cy="1092.8" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A21801C  South Africa=6 [42.9%]  surface glycoprotein, D80A</title>
	<circle cx="1017.5" cy="1062.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A22206G  South Africa=3 [21.4%]  surface glycoprotein, D215G</title>
	<circle cx="945.5" cy="1008.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  C22227T  Tunisia=2 [50.0%]  surface glycoprotein, A222V</title>
	<circle cx="941.7" cy="1005.4" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G22299T  South Africa=3 [21.4%]  surface glycoprotein, R246I</title>
	<circle cx="928.9" cy="995.7" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G22813T  South Africa=6 [42.9%]  surface glycoprotein, K417N</title>
	<circle cx="837.5" cy="926.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G22992A  Tunisia=2 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="805.7" cy="902.8" r="1.2" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  G23012A  South Africa=6 [42.9%]  surface glycoprotein, E484K</title>
	<circle cx="802.1" cy="900.2" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23063T  South Africa=6 [42.9%]  surface glycoprotein, N501Y</title>
	<circle cx="793.0" cy="893.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23403G  South Africa=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="847.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  A23403G  South Africa=14 [100.0%] Tunisia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="732.6" cy="847.8" r="2.4" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-02  C23664T  South Africa=6 [42.9%]  surface glycoprotein, A701V</title>
	<circle cx="686.1" cy="812.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03 South Africa: 8 samples</title>
	<line x1="1184.2" y1="1187.7" x2="1180.9" y2="1185.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-03  A21801C  South Africa=3 [37.5%]  surface glycoprotein, D80A</title>
	<circle cx="1019.9" cy="1059.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G22813T  South Africa=3 [37.5%]  surface glycoprotein, K417N</title>
	<circle cx="842.3" cy="920.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  G23012A  South Africa=3 [37.5%]  surface glycoprotein, E484K</title>
	<circle cx="807.4" cy="893.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  A23063T  South Africa=3 [37.5%]  surface glycoprotein, N501Y</title>
	<circle cx="798.4" cy="886.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  A23403G  South Africa=7 [87.5%]  surface glycoprotein, D614G</title>
	<circle cx="738.8" cy="839.7" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-03  C23664T  South Africa=3 [37.5%]  surface glycoprotein, A701V</title>
	<circle cx="693.0" cy="803.9" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04 South Africa: 13 samples</title>
	<line x1="1184.5" y1="1187.4" x2="1180.4" y2="1184.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-04  A21801C  South Africa=5 [38.5%]  surface glycoprotein, D80A</title>
	<circle cx="1022.4" cy="1056.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A22206G  South Africa=4 [30.8%]  surface glycoprotein, D215G</title>
	<circle cx="952.3" cy="999.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G22813T  South Africa=5 [38.5%]  surface glycoprotein, K417N</title>
	<circle cx="847.3" cy="914.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  G23012A  South Africa=5 [38.5%]  surface glycoprotein, E484K</title>
	<circle cx="812.8" cy="886.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A23063T  South Africa=5 [38.5%]  surface glycoprotein, N501Y</title>
	<circle cx="804.0" cy="879.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  A23403G  South Africa=13 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="745.1" cy="831.7" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-04  C23664T  South Africa=5 [38.5%]  surface glycoprotein, A701V</title>
	<circle cx="700.0" cy="795.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05 South Africa: 16 samples</title>
	<line x1="1184.7" y1="1187.1" x2="1180.4" y2="1183.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-05  A21801C  South Africa=5 [31.2%]  surface glycoprotein, D80A</title>
	<circle cx="1025.0" cy="1053.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  A22206G  South Africa=2 [12.5%]  surface glycoprotein, D215G</title>
	<circle cx="955.9" cy="995.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G22299T  South Africa=2 [12.5%]  surface glycoprotein, R246I</title>
	<circle cx="940.0" cy="981.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G22813T  South Africa=5 [31.2%]  surface glycoprotein, K417N</title>
	<circle cx="852.3" cy="908.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  G23012A  South Africa=5 [31.2%]  surface glycoprotein, E484K</title>
	<circle cx="818.3" cy="879.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  A23063T  South Africa=5 [31.2%]  surface glycoprotein, N501Y</title>
	<circle cx="809.6" cy="872.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  A23403G  South Africa=16 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="751.6" cy="823.8" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-05  C23664T  South Africa=5 [31.2%]  surface glycoprotein, A701V</title>
	<circle cx="707.1" cy="786.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06 South Africa: 7 samples</title>
	<line x1="1184.9" y1="1186.9" x2="1181.8" y2="1184.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-06  A21801C  South Africa=4 [57.1%]  surface glycoprotein, D80A</title>
	<circle cx="1027.5" cy="1050.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G22299T  South Africa=2 [28.6%]  surface glycoprotein, R246I</title>
	<circle cx="943.8" cy="977.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G22813T  South Africa=4 [57.1%]  surface glycoprotein, K417N</title>
	<circle cx="857.4" cy="902.2" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  G23012A  South Africa=4 [57.1%]  surface glycoprotein, E484K</title>
	<circle cx="824.0" cy="873.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23063T  South Africa=4 [57.1%]  surface glycoprotein, N501Y</title>
	<circle cx="815.4" cy="865.7" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  A23403G  South Africa=7 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="758.3" cy="816.0" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-06  C23664T  South Africa=4 [57.1%]  surface glycoprotein, A701V</title>
	<circle cx="714.4" cy="777.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07 South Africa: 6 samples</title>
	<line x1="1185.1" y1="1186.6" x2="1182.3" y2="1184.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-07  A23403G  South Africa=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="765.0" cy="808.4" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-07  G25455T  South Africa=2 [33.3%]  ORF3a protein, K21N</title>
	<circle cx="425.4" cy="502.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08 South Africa: 3 samples</title>
	<line x1="1185.4" y1="1186.4" x2="1183.4" y2="1184.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-08 Tunisia: 6 samples</title>
	<line x1="1183.4" y1="1184.5" x2="1180.6" y2="1181.9" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-08  G22022C  South Africa=2 [66.7%]  surface glycoprotein, E154Q</title>
	<circle cx="996.9" cy="1010.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  G22992A  Tunisia=3 [50.0%]  surface glycoprotein, S477N</title>
	<circle cx="838.9" cy="863.3" r="1.9" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  T23031C  South Africa=2 [66.7%]  surface glycoprotein, F490S</title>
	<circle cx="832.5" cy="857.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  A23403G  Tunisia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="800.8" r="3.1" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  A23403G  Tunisia=6 [100.0%] South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="771.9" cy="800.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-08  A24062G  South Africa=2 [66.7%]  surface glycoprotein, I834V</title>
	<circle cx="664.6" cy="700.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-09 South Africa: 3 samples</title>
	<line x1="1185.6" y1="1186.1" x2="1183.7" y2="1184.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-09  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="779.0" cy="793.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11 South Africa: 8 samples</title>
	<line x1="1186.1" y1="1185.6" x2="1183.1" y2="1182.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-11  C21614T  South Africa=3 [37.5%]  surface glycoprotein, L18F</title>
	<circle cx="1070.2" cy="1065.6" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  A21801C  South Africa=8 [100.0%]  surface glycoprotein, D80A</title>
	<circle cx="1041.3" cy="1035.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  A22206G  South Africa=8 [100.0%]  surface glycoprotein, D215G</title>
	<circle cx="978.6" cy="970.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  T22287A  South Africa=8 [100.0%]  surface glycoprotein, L242H</title>
	<circle cx="966.1" cy="957.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  G22813T  South Africa=8 [100.0%]  surface glycoprotein, K417N</title>
	<circle cx="884.7" cy="873.5" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  G23012A  South Africa=8 [100.0%]  surface glycoprotein, E484K</title>
	<circle cx="853.9" cy="841.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  A23063T  South Africa=8 [100.0%]  surface glycoprotein, N501Y</title>
	<circle cx="846.0" cy="833.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="793.4" cy="779.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-11  C23664T  South Africa=8 [100.0%]  surface glycoprotein, A701V</title>
	<circle cx="753.0" cy="737.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12 South Africa: 21 samples</title>
	<line x1="1186.4" y1="1185.4" x2="1182.2" y2="1181.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-12  C21614T  South Africa=3 [14.3%]  surface glycoprotein, L18F</title>
	<circle cx="1072.6" cy="1063.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  A21801C  South Africa=20 [95.2%]  surface glycoprotein, D80A</title>
	<circle cx="1044.2" cy="1032.9" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  A22206G  South Africa=12 [57.1%]  surface glycoprotein, D215G</title>
	<circle cx="982.6" cy="966.9" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  T22287A  South Africa=6 [28.6%]  surface glycoprotein, L242H</title>
	<circle cx="970.3" cy="953.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G22299T  South Africa=6 [28.6%]  surface glycoprotein, R246I</title>
	<circle cx="968.5" cy="951.8" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G22813T  South Africa=17 [81.0%]  surface glycoprotein, K417N</title>
	<circle cx="890.4" cy="868.0" r="4.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  G23012A  South Africa=20 [95.2%]  surface glycoprotein, E484K</title>
	<circle cx="860.2" cy="835.6" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  A23063T  South Africa=20 [95.2%]  surface glycoprotein, N501Y</title>
	<circle cx="852.5" cy="827.3" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  A23403G  South Africa=21 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="800.8" cy="771.9" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-12  C23664T  South Africa=21 [100.0%]  surface glycoprotein, A701V</title>
	<circle cx="761.2" cy="729.4" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13 South Africa: 23 samples</title>
	<line x1="1186.6" y1="1185.1" x2="1182.5" y2="1180.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-13  C21614T  South Africa=4 [17.4%]  surface glycoprotein, L18F</title>
	<circle cx="1075.0" cy="1061.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A21801C  South Africa=20 [87.0%]  surface glycoprotein, D80A</title>
	<circle cx="1047.1" cy="1030.2" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A22206G  South Africa=13 [56.5%]  surface glycoprotein, D215G</title>
	<circle cx="986.7" cy="963.2" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  T22287A  South Africa=2 [8.7%]  surface glycoprotein, L242H</title>
	<circle cx="974.7" cy="949.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G22299T  South Africa=7 [30.4%]  surface glycoprotein, R246I</title>
	<circle cx="972.9" cy="947.8" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G22813T  South Africa=20 [87.0%]  surface glycoprotein, K417N</title>
	<circle cx="896.3" cy="862.7" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G23012A  South Africa=20 [87.0%]  surface glycoprotein, E484K</title>
	<circle cx="866.6" cy="829.8" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A23063T  South Africa=19 [82.6%]  surface glycoprotein, N501Y</title>
	<circle cx="859.0" cy="821.3" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  A23403G  South Africa=22 [95.7%]  surface glycoprotein, D614G</title>
	<circle cx="808.4" cy="765.0" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  C23664T  South Africa=21 [91.3%]  surface glycoprotein, A701V</title>
	<circle cx="769.5" cy="721.8" r="5.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-13  G25145C  South Africa=2 [8.7%]  surface glycoprotein, E1195Q</title>
	<circle cx="548.8" cy="476.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-14 South Africa: 4 samples</title>
	<line x1="1186.9" y1="1184.9" x2="1184.8" y2="1182.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-14  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="816.0" cy="758.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15 South Africa: 8 samples</title>
	<line x1="1187.1" y1="1184.7" x2="1184.4" y2="1181.4" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-15  A21801C  South Africa=2 [25.0%]  surface glycoprotein, D80A</title>
	<circle cx="1053.1" cy="1025.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  A22206G  South Africa=2 [25.0%]  surface glycoprotein, D215G</title>
	<circle cx="995.1" cy="955.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  T22287A  South Africa=2 [25.0%]  surface glycoprotein, L242H</title>
	<circle cx="983.5" cy="942.0" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G22813T  South Africa=2 [25.0%]  surface glycoprotein, K417N</title>
	<circle cx="908.2" cy="852.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  G23012A  South Africa=3 [37.5%]  surface glycoprotein, E484K</title>
	<circle cx="879.8" cy="818.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  A23063T  South Africa=2 [25.0%]  surface glycoprotein, N501Y</title>
	<circle cx="872.5" cy="809.6" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  A23403G  South Africa=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="823.8" cy="751.6" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-15  C23664T  South Africa=2 [25.0%]  surface glycoprotein, A701V</title>
	<circle cx="786.4" cy="707.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16 South Africa: 9 samples</title>
	<line x1="1187.4" y1="1184.5" x2="1184.6" y2="1181.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-16  G22992A  South Africa=4 [44.4%]  surface glycoprotein, S477N</title>
	<circle cx="889.3" cy="816.3" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  A23403G  South Africa=9 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="831.7" cy="745.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-16  C25427T  South Africa=4 [44.4%]  ORF3a protein, T12I</title>
	<circle cx="548.0" cy="394.8" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-17 South Africa: 3 samples</title>
	<line x1="1187.7" y1="1184.2" x2="1186.0" y2="1182.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-17  A23403G  South Africa=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="839.7" cy="738.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18 South Africa: 14 samples</title>
	<line x1="1188.0" y1="1184.0" x2="1184.8" y2="1179.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-18  C21614T  South Africa=3 [21.4%]  surface glycoprotein, L18F</title>
	<circle cx="1087.5" cy="1050.8" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A21801C  South Africa=10 [71.4%]  surface glycoprotein, D80A</title>
	<circle cx="1062.5" cy="1017.5" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A22206G  South Africa=6 [42.9%]  surface glycoprotein, D215G</title>
	<circle cx="1008.2" cy="945.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  T22287A  South Africa=9 [64.3%]  surface glycoprotein, L242H</title>
	<circle cx="997.3" cy="931.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22299T  South Africa=4 [28.6%]  surface glycoprotein, R246I</title>
	<circle cx="995.7" cy="928.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22813T  South Africa=9 [64.3%]  surface glycoprotein, K417N</title>
	<circle cx="926.8" cy="837.5" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G22992A  South Africa=2 [14.3%]  surface glycoprotein, S477N</title>
	<circle cx="902.8" cy="805.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  G23012A  South Africa=9 [64.3%]  surface glycoprotein, E484K</title>
	<circle cx="900.2" cy="802.1" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A23063T  South Africa=9 [64.3%]  surface glycoprotein, N501Y</title>
	<circle cx="893.3" cy="793.0" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  A23403G  South Africa=14 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="847.8" cy="732.6" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C23664T  South Africa=10 [71.4%]  surface glycoprotein, A701V</title>
	<circle cx="812.8" cy="686.1" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-18  C25427T  South Africa=2 [14.3%]  ORF3a protein, T12I</title>
	<circle cx="576.5" cy="372.5" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19 South Africa: 16 samples</title>
	<line x1="1188.2" y1="1183.8" x2="1185.0" y2="1179.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-19 Cameroon: 3 samples</title>
	<line x1="1185.0" y1="1179.3" x2="1183.4" y2="1177.1" style="stroke:#CC00FF;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-19  A21801C  South Africa=14 [87.5%]  surface glycoprotein, D80A</title>
	<circle cx="1065.7" cy="1015.1" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G22205C  Cameroon=2 [66.7%]  surface glycoprotein, D215H</title>
	<circle cx="1012.8" cy="942.3" r="1.2" style="fill:#CC00FF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A22206G  South Africa=5 [31.2%]  surface glycoprotein, D215G</title>
	<circle cx="1012.7" cy="942.2" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  T22287A  South Africa=12 [75.0%]  surface glycoprotein, L242H</title>
	<circle cx="1002.1" cy="927.6" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G22299T  South Africa=9 [56.2%]  surface glycoprotein, R246I</title>
	<circle cx="1000.5" cy="925.4" r="3.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G22813T  South Africa=14 [87.5%]  surface glycoprotein, K417N</title>
	<circle cx="933.2" cy="832.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  G23012A  South Africa=14 [87.5%]  surface glycoprotein, E484K</title>
	<circle cx="907.2" cy="796.9" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A23063T  South Africa=14 [87.5%]  surface glycoprotein, N501Y</title>
	<circle cx="900.5" cy="787.7" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A23403G  South Africa=16 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="726.5" r="4.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  A23403G  South Africa=16 [100.0%] Cameroon=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="856.0" cy="726.5" r="1.9" style="fill:#CC00FF;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-19  C23664T  South Africa=15 [93.8%]  surface glycoprotein, A701V</title>
	<circle cx="821.8" cy="679.5" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20 South Africa: 15 samples</title>
	<line x1="1188.5" y1="1183.6" x2="1185.4" y2="1179.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-20  C21614T  South Africa=2 [13.3%]  surface glycoprotein, L18F</title>
	<circle cx="1092.8" cy="1046.9" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A21801C  South Africa=14 [93.3%]  surface glycoprotein, D80A</title>
	<circle cx="1068.9" cy="1012.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A22206G  South Africa=10 [66.7%]  surface glycoprotein, D215G</title>
	<circle cx="1017.2" cy="938.9" r="4.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  T22287A  South Africa=15 [100.0%]  surface glycoprotein, L242H</title>
	<circle cx="1006.8" cy="924.2" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G22299T  South Africa=4 [26.7%]  surface glycoprotein, R246I</title>
	<circle cx="1005.3" cy="922.0" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G22813T  South Africa=15 [100.0%]  surface glycoprotein, K417N</title>
	<circle cx="939.7" cy="828.2" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  G23012A  South Africa=15 [100.0%]  surface glycoprotein, E484K</title>
	<circle cx="914.2" cy="791.9" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A23063T  South Africa=15 [100.0%]  surface glycoprotein, N501Y</title>
	<circle cx="907.7" cy="782.6" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  A23403G  South Africa=15 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="864.3" cy="720.5" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-20  C23664T  South Africa=15 [100.0%]  surface glycoprotein, A701V</title>
	<circle cx="830.9" cy="672.9" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-23 Tunisia: 5 samples</title>
	<line x1="1189.4" y1="1183.0" x2="1187.5" y2="1180.1" style="stroke:#6495ED;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-23  A23403G  Tunisia=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="889.8" cy="703.6" r="2.8" style="fill:#6495ED;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24 South Africa: 26 samples</title>
	<line x1="1189.7" y1="1182.9" x2="1186.4" y2="1177.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-24 SouthAfrica: 2 samples</title>
	<line x1="1186.4" y1="1177.3" x2="1185.3" y2="1175.5" style="stroke:#80b1d3;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-24  C21614T  South Africa=2 [7.7%]  surface glycoprotein, L18F</title>
	<circle cx="1103.8" cy="1039.8" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A21801C  South Africa=24 [92.3%]  surface glycoprotein, D80A</title>
	<circle cx="1082.3" cy="1004.1" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A22206G  South Africa=11 [42.3%]  surface glycoprotein, D215G</title>
	<circle cx="1035.9" cy="926.8" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  T22287A  South Africa=22 [84.6%]  surface glycoprotein, L242H</title>
	<circle cx="1026.6" cy="911.4" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G22299T  South Africa=11 [42.3%]  surface glycoprotein, R246I</title>
	<circle cx="1025.2" cy="909.1" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G22813T  South Africa=24 [92.3%]  surface glycoprotein, K417N</title>
	<circle cx="966.2" cy="810.9" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G22813T  South Africa=24 [92.3%] SouthAfrica=2 [100.0%]  surface glycoprotein, K417N</title>
	<circle cx="966.2" cy="810.9" r="1.2" style="fill:#80b1d3;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G23012A  South Africa=24 [92.3%]  surface glycoprotein, E484K</title>
	<circle cx="943.4" cy="772.9" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  G23012A  South Africa=24 [92.3%] SouthAfrica=2 [100.0%]  surface glycoprotein, E484K</title>
	<circle cx="943.4" cy="772.9" r="1.2" style="fill:#80b1d3;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23063T  South Africa=24 [92.3%]  surface glycoprotein, N501Y</title>
	<circle cx="937.5" cy="763.2" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23063T  South Africa=24 [92.3%] SouthAfrica=2 [100.0%]  surface glycoprotein, N501Y</title>
	<circle cx="937.5" cy="763.2" r="1.2" style="fill:#80b1d3;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23403G  South Africa=26 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="698.3" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  A23403G  South Africa=26 [100.0%] SouthAfrica=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="898.5" cy="698.3" r="1.2" style="fill:#80b1d3;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C23664T  South Africa=24 [92.3%]  surface glycoprotein, A701V</title>
	<circle cx="868.6" cy="648.5" r="5.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-24  C23664T  South Africa=24 [92.3%] SouthAfrica=2 [100.0%]  surface glycoprotein, A701V</title>
	<circle cx="868.6" cy="648.5" r="1.2" style="fill:#80b1d3;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25 South Africa: 12 samples</title>
	<line x1="1190.0" y1="1182.7" x2="1187.5" y2="1178.3" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-25  C21614T  South Africa=2 [16.7%]  surface glycoprotein, L18F</title>
	<circle cx="1106.6" cy="1038.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A21801C  South Africa=5 [41.7%]  surface glycoprotein, D80A</title>
	<circle cx="1085.7" cy="1002.1" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A22206G  South Africa=3 [25.0%]  surface glycoprotein, D215G</title>
	<circle cx="1040.6" cy="924.0" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  T22287A  South Africa=5 [41.7%]  surface glycoprotein, L242H</title>
	<circle cx="1031.6" cy="908.4" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G22299T  South Africa=2 [16.7%]  surface glycoprotein, R246I</title>
	<circle cx="1030.3" cy="906.1" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G22813T  South Africa=5 [41.7%]  surface glycoprotein, K417N</title>
	<circle cx="973.1" cy="806.9" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G23012A  South Africa=5 [41.7%]  surface glycoprotein, E484K</title>
	<circle cx="950.9" cy="768.5" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23063T  South Africa=5 [41.7%]  surface glycoprotein, N501Y</title>
	<circle cx="945.2" cy="758.7" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  A23403G  South Africa=11 [91.7%]  surface glycoprotein, D614G</title>
	<circle cx="907.3" cy="693.1" r="4.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  C23664T  South Africa=5 [41.7%]  surface glycoprotein, A701V</title>
	<circle cx="878.3" cy="642.8" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-25  G25273T  South Africa=3 [25.0%]  surface glycoprotein, M1237I</title>
	<circle cx="699.1" cy="332.4" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-11-26 South Africa: 4 samples</title>
	<line x1="1190.3" y1="1182.5" x2="1188.8" y2="1179.8" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-11-26  A23403G  South Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="916.2" cy="688.1" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-03 South Africa: 2 samples</title>
	<line x1="1192.5" y1="1181.5" x2="1191.7" y2="1179.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-03  A23403G  South Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="980.7" cy="657.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07 South Africa: 5 samples</title>
	<line x1="1193.8" y1="1181.0" x2="1192.7" y2="1177.6" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-07  C22227T  South Africa=2 [40.0%]  surface glycoprotein, A222V</title>
	<circle cx="1100.1" cy="892.4" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  A23403G  South Africa=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1019.1" cy="643.3" r="2.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  C23664T  South Africa=3 [60.0%]  surface glycoprotein, A701V</title>
	<circle cx="1001.2" cy="588.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G25186T  South Africa=2 [40.0%]  surface glycoprotein, Q1208H</title>
	<circle cx="896.4" cy="265.7" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-07  G25273T  South Africa=2 [40.0%]  surface glycoprotein, M1237I</title>
	<circle cx="890.4" cy="247.2" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-14 Morocco: 2 samples</title>
	<line x1="1196.2" y1="1180.4" x2="1195.8" y2="1178.3" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-14  A23403G  Morocco=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1088.3" cy="625.5" r="1.2" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-15 Morocco: 2 samples</title>
	<line x1="1196.5" y1="1180.3" x2="1196.2" y2="1178.2" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-15  A23403G  Morocco=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1098.4" cy="623.6" r="1.2" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2020-12-21 Morocco: 5 samples</title>
	<line x1="1198.6" y1="1180.0" x2="1198.4" y2="1176.6" style="stroke:#FFD700;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2020-12-21  A23403G  Morocco=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1159.2" cy="616.1" r="2.8" style="fill:#FFD700;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<rect x="1865" y="140" width="500" height="135" rx="15" style="fill:gainsboro;stroke-width:0;fill-opacity:0.15;" />
<text font-size="1.8em" x="1880" y="170" fill="white">Data from 32 countries in Africa</text>
<text font-size="1.8em" x="1880" y="200" fill="white">Genomes/year≥10  Genomes/day≥2</text>
<text font-size="1.8em" x="1880" y="230" fill="white">66 distinct missense variants mapped</text>
<text font-size="1.8em" x="1880" y="260" fill="white">Updated 2021-01-21</text>
</svg>
